|
Prognosis and
Outcome top |
|
|
Contents
|
|
|
|
|
|
|
Astrocytic
Tumors
|
 
|
|
|
Arienti VM, Botturi A, Boiardi A, Broggi G, Collice M, Fariselli L,
Zanni D, Botturi M
Adult
brain low-grade astrocytomas: survival after surgery and radiotherapy
Neurol
Sci 2001 Jun;22(3):233-8
Links
|
|
D.
C. Bowers, P. Kapur, N. J. Winick, L. R. Margraf
MIB-1 labeling index as a predictor of tumor
progression in pilocytic astrocytomas in children and adolescents
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003.
Abstract No. 445
|
|
|
Alba A. Brandes, Linda Nicolardi,
Alicia Tosoni, Marina Gardiman, Paolo Iuzzolino,
Claudio Ghimenton, Michele Reni, Antonino
Rotilio, Guido Sotti and Mario Ermani
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Neuro-oncol 2006 Jul 1; 8(3):253-260; Epub 2006 May 24
Abstract
|
|
Daniel
J. Brat, Wendy F. Seiferheld, Arie Perry, Elizabeth H. Hammond, Kevin J. M Urray,
Alan R. Schulsinger, Minesh P. Mehta, Walter J. Curran
Analysis
of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using
fluorescence in situ hybridization on tissue microarrays from Radiation Therapy
Oncology Group trials
Neuro-Oncology,
April 2004, Volume 6, Number 2, Pages 96 – 103.
|
|
Burkhard C, Di Patre PL, Schuler D, Schuler G, Yasargil MG,
Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H
A
population-based study of the incidence and survival rates in patients with
pilocytic astrocytoma
J Neurosurg. 2003 Jun;98(6):1170-4
|
|
Basil F. El-Rayes, Camille S. Norton,
Wael Sakr, Zosia Maciorowski, Daryn Smith, Haline Pietraszkiewicz,
Maria Del Mar Alonso and John F. Ensley
Cellular DNA content parameters as
prognostic indicators in human astrocytomas
 Journal
of Neuro-Oncology, 71(2):
85-89, January 2005. (Abstract+)
|
|
|
Chaichana
KL, Parker SL, Olivi A, Quiñones-Hinojosa A
Long-term seizure outcomes in adult patients undergoing primary resection of
malignant brain astrocytomas
J Neurosurg. 2009 Apr 3;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Giannini
C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP
Pleomorphic
xanthoastrocytoma: what do we really know about it?
Cancer. 1999 May
1;85(9):2033-45.
|
|
Hanzely
Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, Afra D
Role
of early radiotherapy in the treatment of supratentorial WHO Grade II
astrocytomas: long-term results of 97 patients
J Neurooncol. 2003 Jul;63(3):305-12
|
|
Hwang SL,
Yang YH, Lieu AS, Chuang MC, Chang SJ, Chang YY, Lin HJ, Howng SL
The
conditional survival statistics for survivors with primary supratentorial
astrocytic tumors
J Neurooncol. 2000 Dec;50(3):257-64.
|
|
Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM,
Berger MS.
Volumetric extent of resection and residual
contrast enhancement on initial surgery as predictors of outcome in adult
patients with hemispheric anaplastic astrocytoma.
J Neurosurg.
2006 Jul;105(1):34-40.
Abstract
|
Reprint
|
|
Kirla
RM, Haapasalo HK, Kalimo H, Salminen EK
Low
expression of p27 indicates a poor prognosis in patients with high-grade
astrocytomas
Cancer 2003 Feb 1;97(3):644-8
|
|
|
Kostic
A, Mihailovic D, Veselinovic S, Tasic G, Radulovic D, Stefanovic I.
Peritumoral edema and karyometric variables in astrocytoma of the brain.
J
BUON. 2007 Apr-Jun;12(2):239-43.
PMID: 17600879 [PubMed - in process]
|
|
Lin CL, Lieu AS, Lee KS, Yang YH, Kuo TH, Hung MH, Loh JK, Yen CP,
Chang CZ, Howng SL, Hwang SL
The
conditional probabilities of survival in patients with anaplastic
astrocytoma or glioblastoma multiforme
Surg Neurol.
2003 Nov;60(5):402-6.
|
|
|
Matthew
J. McGirt,MD; Frank Attenello,MS; Muraya Gathinji,MS; Khoi Than,MD; Kaisorn
L. Chaichana,BS; Ghazala Datoo,BS; Alessandro Olivi,MD; Jon D. Weingart ,MD;
Henry Brem, MD; Alfredo Quinones-Hinojosa,MD
Association of preoperative depression and survival
after primary resection of malignant brain astrocytoma
Abstract |
 News |
Links | BL 7:10
|
|
|
McGirt
MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, Olivi A, Quiñones-Hinojosa
A
Persistent
outpatient hyperglycemia is independently associated with decreased survival
after primary resection of malignant brain astrocytomas
Neurosurgery. 2008
Aug;63(2):286-91
Abstract |
Links |
Issue
|
|
|
Minehan
KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP
Prognosis
and treatment of spinal cord astrocytoma
Int
J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):727-33. Epub 2008 Aug 5
Abstract |
Links |
Issue
|
|
Christian
Plathow M.D., Daniela Schulz-Ertner M.D., Christoph Thilman M.D., Ivan
Zuna Ph.D., Mathias Lichy M.D., Marc-André Weber M.D., Heinz-Peter
Schlemmer M.D., Michael Wannenmacher M.D. and Jürgen Debus M.D., Ph.D.
Fractionated
stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and
prognostic factors
Int J of
Radiation Oncology*Biology*Physics, Volume 57, Issue 4, 15 November 2003,
Pages 996-1003
|
|
Ravi
D Rao, Bernd W Scheithauer, Caterina Giannini, Nancy L Iturria, Judith
R O'Fallon, Paul L Schaefer, Jan C Buckner
Prognostic
significance of histologic subtyping in high grade astrocytoma: North
Central Cancer Treatment Group (NCCTG) results
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 283
|
|
Stella
M. Ranuncolo, Mirta
Varela, Ana Morandi, José Lastiri, Silvia Christiansen, Elisa Bal de Kier
Joffé, María G. Pallotta, Lydia Puricelli
Prognostic Value of
Mdm2, p53 and p16 in Patients with Astrocytomas
Journal of Neuro-Oncology, 68 (2): 113-121, June 2004.
(Abstract+)
|
|
|
Sathornsumetee S, Cao Y, Marcello JE, Herndon JE
2nd, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW, Vredenburgh JJ,
Rich JN
Tumor angiogenic and hypoxic profiles predict radiographic response and
survival in malignant astrocytoma patients treated with bevacizumab and
irinotecan
J
Clin Oncol. 2008 Jan 10;26(2):271-8
Abstract |
Links | BL 7:6
|
|
Torp
SH
Diagnostic
and prognostic role of Ki67 immunostaining in human astrocytomas using
four different antibodies
Clin Neuropathol 2002 Nov-Dec;21(6):252-7
|
|
Wessels
PH, Hopman AH, Kubat B, Kessels AG, Hoving
EW, Ummelen MI, Ramaekers
FC, Twijnstra A
Proliferation
and aneusomy predict survival of young patients with astrocytoma grade II
Br J Cancer. 2003 Jul 7;89(1):128-34
|
|
|
Zuzak
TJ, Poretti A, Drexel B, Zehnder D, Boltshauser E, Grotzer MA
Outcome
of children with low-grade cerebellar astrocytoma: long-term complications
and quality of life
Childs
Nerv Syst. 2008 Dec;24(12):1447-55. Epub 2008 Aug 9
Abstract |
Links |
Issue
|
|
Anaplastic
Astrocytomas
|
|
|
|
Nagy M, Schulz-Ertner D, Bischof M, Welzel T, Hof H, Debus J,
Combs SE
Long-term outcome of postoperative irradiation in patients with newly
diagnosed WHO grade III anaplastic gliomas
Tumori. 2009 May-Jun;95(3):317-24
Abstract |
Links |
Issue
|
|
|
Sadones J, Michotte A, Veld P, Chaskis C, Sciot
R, Menten J, Joossens EJ, Strauven T, D'Hondt LA, Sartenaer D, Califice SF,
Bierau K, Svensson C, De Grève J, Neyns B.
MGMT promoter hypermethylation correlates with a survival benefit from
temozolomide in patients with recurrent anaplastic astrocytoma but not
glioblastoma
Eur J Cancer. 2008 Oct 20; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Pilocytic
astrocytoma
|
|
|
|
Daszkiewicz
P, Maryniak A, Roszkowski M, Barszcz S
Long-term functional outcome of surgical treatment of juvenile pilocytic
astrocytoma of the cerebellum in children
Childs
Nerv Syst. 2009 Jul;25(7):855-60. Epub 2009 May 6
Abstract |
Links |
CNO 8(10)
|
|
|
Brain
Tumors
|
|
|
|
Davis
FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML
The conditional probability of survival of patients
with primary malignant brain tumors: surveillance, epidemiology, and end
results (SEER) data
Cancer. 1999 Jan 15;85(2):485-91.
|
|
|
Furneaux CE, Marshall ES, Yeoh K, Monteith SJ,
Mews PJ, Sansur CA, Oskouian RJ, Sharples KJ, Baguley BC.
Cell cycle times of short-term cultures of brain cancers as predictors of
survival
Br J Cancer. 2008 Oct 14; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Lori
A. Holmquist, Jim Scott
Treatment, Age, and Time-Related Predictors of
Behavioral Outcome in Pediatric Brain Tumor Survivors
Journal of Clinical Psychology in Medical Settings, 9 (4): 315-321, December
2002
|
|
T. B. Johannesen, F. Langmark and K. Lote
Cause of death and long-term survival in patients
with neuro-epithelial brain tumours: a population-based study
European Journal of Cancer, Volume 39, Issue 16 , November 2003, Pages 2355-2363
|
|
B.
E. Lally, J. Lacy, J. M. Piepmeier, J. M. Baehring, D. B. Fischer, J.
P. S. Knisely
Survival
analysis for patients with primary brain tumors treated with temozolomide
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract
No. 453
|
| |
Yael
Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier,
Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain
tumor response to radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547
|
| |
Mardor Y,
Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A,
Baram J, Orenstein A, Cohen JS, Tichler T
Early
Detection of Response to Radiation Therapy in Patients With Brain Malignancies
Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance
Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100
|
|
Helen McCarter, William
Furlong, Anthony C. Whitton, David Feeny,
Sonja DePauw, Andrew R. Willan, Ronald D.
Barr
Health Status Measurements at Diagnosis
As Predictors of Survival Among Adults With Brain Tumors
Journal of Clinical Oncology, Vol 24, No 22 (August 1), 2006: pp.
3636-3643, DOI: 10.1200/JCO.2006.06.0137
|
|
Meyers
CA, Hess KR
Multifaceted
end points in brain tumor clinical trials: Cognitive deterioration
precedes MRI progression
Neuro-oncol 2003 Apr;5(2):89-95
|
|
|
Pang
J, Banerjee A, Tihan T.
The value of tandem CSF/MRI evaluation for predicting disseminated disease
in childhood central nervous system neoplasms.
J Neurooncol.
2007 Nov 7; [Epub ahead of print]
Abstract
|
|
|
Rachet B, Mitry E, Quinn MJ, Cooper N, Coleman
MP.
Survival from brain tumours in England and Wales up to 2001
Br J Cancer.
2008 Sep 23;99 Suppl 1:S98-101
 Reference |
 Full Text |
Reprint |
Links | BL 7:20
|
|
|
Schmidt LS, Nielsen H, Schmiedel S, Johansen C.
Social inequality and incidence of and survival from tumours of the
central nervous system in a population-based study in Denmark, 1994-2003
Eur
J Cancer. 2008 Sep;44(14):2050-7.
Epub 2008 Jul 28
Abstract |
Links |
Issue
|
|
A
A. Tzika, Loukas G. Astrakas, David
Zurakowski, Maria K. Zarifi, Tina P.
Young, Liliana Goumnerova, Douglas C. Anthony, Mark Kieran, Nancy J. Tarbell,
Peter M. Black
Predicting progression in children with
pediatric brain tumors using magnetic resonance neuroimaging
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 3411
|
|
|
Brainstem
Gliomas
|
|
|
|
|
Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R,
Krieger MD, Gilles FH, Blüml S.
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol. 2007
Nov 14; [Epub ahead of print]
Abstract
|
Links
|
|
|
Central
Neurocytoma |
|
|
|
Rades D, Schild SE, Fehlauer F
Prognostic value of the MIB-1 labeling index for
central neurocytomas
Neurology. 2004 Mar 23;62(6):987-9
|
|
|
Choriocarcinoma
|
|
|
|
Shinoda J, Sakai N, Yano H, Hattori T, Ohkuma A,
Sakaguchi H
Prognostic factors and therapeutic problems of
primary intracranial choriocarcinoma/germ-cell tumors with high levels of
HCG
J Neurooncol. 2004 Jan;66(1-2):225-40
|
|
|
Craniopharyngioma |
|
|
|
Losa M, Vimercati A, Acerno S, Barzaghi
RL, Mortini P, Mangili F, Terreni MR, Santambrogio G, Giovanelli M
Correlation between clinical characteristics and
proliferative activity in patients with craniopharyngioma
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):889-92
|
|
|
Ependymal
Tumors
|
|
|
|
Altura RA,
Olshefski RS, Jiang Y, Boue DR
Nuclear
expression of Survivin in paediatric ependymomas and choroid plexus tumours
correlates with morphologic tumour grade
Br J Cancer. 2003 Nov 3;89(9):1743-9
|
|
D. R. Gomez, B. T. Missett,
W. M. Wara, D. A. Larson, P. K. Sneed, M. D. Prados, S. M. Chang, M. S.
Berger, N. Gupta, D. A. Haas-Kogan;
High
failure rate in spinal ependymomas with long-term follow-up
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1528
|
|
Tang-Her
Jaing, Huei-Shyong Wang, Pei-Kwei Tsay, Chen-Kan Tseng, Shih-Ming Jung,
Kuang-Lin Lin, Tai-Ngar Lui
Multivariate Analysis of
Clinical Prognostic Factors in Children with Intracranial Ependymomas
Journal of Neuro-Oncology, 68 (3): 255-261, July 2004. (Abstract+)
|
|
|
Kano
H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD
Outcome
predictors for intracranial ependymoma radiosurgery
Neurosurgery. 2009 Feb;64(2):279-87;
Abstract |
Links |
Issue
|
| |
Bong-Soo
Kim, Chanland Roonprapunt, Victoria LaMarca, Karl F Kothbauer, George
I Jallo
The
current management of intracranial ependymomas in children
Annals of Neurosurgery 2002; 2(3), July 2002
|
|
Korshunov A, Golanov A, Sycheva R, Timirgaz V
The histologic grade
is a main prognostic factor for patients with intracranial ependymomas
treated in the microneurosurgical era: an analysis of 258 patients
Cancer. 2004 Mar 15;100(6):1230-7
|
|
|
Metellus P, Figarella-Branger D, Guyotat J,
Barrie M, Giorgi R, Jouvet A, Chinot O; Club de Neuro-Oncologie de la Société
Française de Neurochirurgie and the Association des Neuro-Oncologues
d'Expression Française.
Supratentorial ependymomas: prognostic factors and outcome analysis in a
retrospective series of 46 adult patients
Cancer. 2008 May 9;113(1):175-85
Abstract |
Links |
BL 7:15
|
|
|
Monoranu
CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B,
Roggendorf W
Correlation between 6q25.3 deletion status and survival in pediatric
intracranial ependymomas
Cancer
Genet Cytogenet. 2008 Apr 1;182(1):18-26;
Epub 2008 Mar 6
Abstract |
Links | BL 7:9
|
|
Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande
F, Vastola F, Magli A, Franzin A, Basso U, Villa E
A multicenter study of the prognosis and treatment
of adult brain ependymal tumors
Cancer. 2004 Mar 15;100(6):1221-9
|
|
|
Tabori U, Wong V, Ma J, Shago M, Alon N, Rutka
J, Bouffet E, Bartels U, Malkin D, Hawkins CTabori U, Wong V, Ma J, Shago M,
Alon N, Rutka J, Bouffet E, Bartels U, Malkin D, Hawkins C
Telomere maintenance and dysfunction predict recurrence in paediatric
ependymoma
Br J Cancer.
2008 Oct 7;99(7):1129-35.
Epub 2008 Sep 16
Abstract |
Links |
Issue
|
|
|
Uri Tabori,
Jing Ma, Michael Carter, Maria Zielenska,
James Rutka, Eric Bouffet, Ute Bartels,
David Malkin, Cynthia Hawkins
Human Telomere Reverse Transcriptase Expression Predicts Progression
and Survival in Pediatric Intracranial Ependymoma
Journal of Clinical Oncology, Vol 24, No 10 (April 1), 2006: pp.
1522-1528; DOI: 10.1200/JCO.2005.04.2127
Abstract
|
News
|
|
|
Epilepsy
|
|
|
|
|
Maschio
M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D,
Occhipinti E, Jandolo B.
Outcome and tolerability of topiramate in brain tumor associated epilepsy.
J Neurooncol.
2007 Jun 28; [Epub ahead of print]
PMID: 17598071 [PubMed - as supplied by publisher]
|
|
|
Germinoma
|
|
|
|
|
Kawabata Y, Takahashi JA, Arakawa Y, Shirahata
M, Hashimoto N.
Long term outcomes in patients with intracranial germinomas: a single
institution experience of irradiation with or without chemotherapy
J Neurooncol.
2008 Jun;88(2):161-7.
Epub 2008 Feb 20
Abstract |
Links |
Issue
|
|
|
Ogawa
K, Yoshii Y, Shikama N, Nakamura K, Uno T, Onishi H, Itami J, Shioyama Y,
Iraha S, Hyodo A, Toita T, Kakinohana Y, Tamaki W, Ito H, Murayama S
Spinal
recurrence from intracranial germinoma: risk factors and treatment outcome
for spinal recurrence
Int
J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1347-54. Epub 2008 May 29
Abstract |
Links |
Issue
|
|
Alyssa
T. Reddy, John C. Wellons III, Jeffrey C. Allen, John B. Fiveash,
Hussein Abdullatif, Karen W. Braune, Paul A. Grabb
Refining the staging evaluation of pineal region
germinoma using neuroendoscopy and the presence of preoperative diabetes
insipidus
Neuro-OncologyVolume 6, Number 2, Pages 127 – 133
|
|
|
Glioblastoma
|
|
|
|
|
Affronti
ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh
JJ, Friedman AH, Bigner DD, Friedman HS
Overall
survival of newly diagnosed glioblastoma patients receiving carmustine
wafers followed by radiation and concurrent temozolomide plus rotational
multiagent chemotherapy
Cancer. 2009 Jun 9. [Epub
ahead of print]
Abstract |
Links |
Issue
|
|
|
Aoki H, Yokoyama T, Fujiwara K, Tari AM, Sawaya
R, Suki D, Hess KR, Aldape KD, Kondo S, Kumar R, Kondo Y.
Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter
Survival Time in Patients with Glioblastoma.
Clin
Cancer Res. 2007 Nov 15;13(22):6603-6609.
Abstract
|
Links
|
|
|
Bähr
O, Herrlinger U, Weller M, Steinbach JP.
Very late relapses in glioblastoma long-term survivors
J Neurol. 2009 May 12;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
G. L. Banna, R. Pallini, L. Ricci-Vitiani, M.
Signore, D. Lombardi, M. Martini, G. Maira, D. Giuffrida, L. M. Larocca, and
R. De Maria
High prognostic potential of glioblastoma
stem
cell analysis
ASCO Meeting Abstracts, Jun 2007; 25: 10580
Abstract |
Links | BL 7:2
|
|
Barker
FG 2nd, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK,
McDermott MW, Sneed PK, Wara WM, Wilson CB.
Radiation
response and survival time in patients with glioblastoma multiforme
J Neurosurg 1996
Mar;84(3):442-8
|
|
Barker
FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB
Survival
and functional status after resection of recurrent glioblastoma multiforme
Neurosurgery. 1998 Apr;42(4):709-20
|
|
J.L.
Blanc, M. Wager, J. Guilhot, S. Kusy, B. Bataille, T. Chantereau, F.
Lapierre, C.J. Larsen, L. Karayan-Tapon
Correlation of
Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas
Journal of Neuro-Oncology, 68 (3): 275-283, July 2004. (Abstract+)
|
|
|
Blumenthal
DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM, Rogers CL, Corn BW.
Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients
With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology
Group Database
J Clin Oncol. 2008 Dec 29; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Brandes
AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R,
Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F,
Ermani M.
MGMT promoter methylation status can predict the incidence and outcome of
pseudoprogression after concomitant radiochemotherapy in newly diagnosed
glioblastoma patients
J
Clin Oncol. 2008 May 1;26(13):2192-7
Abstract |
Full Text |
Reprint |
Links |
BL 7:10
|
|
L.
Butttolo, F. Giunta, V. D. Ferrari, G. Marini
Temozolomide
in glioblastoma: 4 years' experience with monthly or fortnigthly schedule
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 437
|
|
|
Chaichana KL, McGirt MJ, Frazier J, Attenello F,
Guerrero-Cazares H, Quinones-Hinojosa
A.
Relationship of glioblastoma multiforme to the lateral ventricles
predicts survival following tumor resection
J Neurooncol.
2008 May 6. [Epub ahead of print]
Abstract |
Links | BL 7:10
|
|
|
Chinnaiyan P, Wang M, Rojiani AM, Tofilon PJ,
Chakravarti A, Ang KK, Zhang HZ, Hammond E, Curran W Jr, Mehta MP.
The prognostic value of nestin expression in newly diagnosed
glioblastoma: report from the Radiation Therapy Oncology Group
Radiat Oncol. 2008 Sep 25;3:32
Abstract |
Full Text |
Reprint |
Links | BL 7:20
|
|
A. K. Choucair, W. Seiferheld, C.
Ford, J. Hansen, B. Dabbas, C. Schultz, A. Schulsinger, M. Mehta, W. Curran
Long term survivors with glioblastoma multiforme
(GBM) treated on RTOG protocols with irradiation and nitrosurea have higher
initial expression of Ki-67
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9661
|
|
|
Crawford FW, Khayal IS, McGue C, Saraswathy S,
Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ.
Relationship of pre-surgery metabolic and physiological MR imaging
parameters to survival for patients with untreated GBM
J Neurooncol. 2008 Nov 15; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Eoli M, Menghi F, Bruzzone MG, De Simone T,
Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L,
Filippini G, Broggi G, Boiardi A, Finocchiaro G.
Methylation of O6-methylguanine DNA methyltransferase and loss of
heterozygosity on 19q and/or 17p are overlapping features of secondary
glioblastomas with prolonged survival
Clin
Cancer Res. 2007 May 1;13(9):2606-13
Abstract |
Full Text |
Reprint |
Links |
BL 7:16
|
|
|
Erpolat
OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber S
Outcome of newly diagnosed glioblastoma patients treated by radiotherapy
plus concomitant and adjuvant temozolomide: a long-term analysis
Tumori. 2009 Mar-Apr;95(2):191-7
Abstract |
Links |
Issue
|
|
|
Filippini G, Falcone C, Boiardi A, Broggi G,
Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G,
Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG.
Prognostic factors for survival in 676 consecutive patients with newly
diagnosed primary glioblastoma.
Neuro Oncol. 2007 Nov 9;. [Epub ahead of print]
Abstract
|
|
|
Fischer Jde S, Carvalho PC, Neves-Ferreira AG,
da Fonseca CO, Perales J, Carvalho Mda G, Domont GB.
Anti-thrombin as a prognostic biomarker candidate for patients with
recurrent glioblastoma multiform under treatment with perillyl alcohol
J Exp Ther Oncol. 2008;7(4):285-90
Abstract |
Links |
Issue
|
|
C. Ford, W. Seiferheld, A. K.
Choucair, J. Hansen, B. Dabbas, C. Schultz, A. Schulsinger, M. Mehta, W. Curran
Evaluation of expression of
DNA repair molecules as a prognostic factor for long-term survivors with
glioblastoma multiforme (GBM) treated on RTOG protocols with irradiation and
nitrosoureas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1509
|
|
Gamburg ES, Regine
WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB.
The
prognostic significance of midline shift at presentation on survival in patients
with glioblastoma multiforme
Int J Radiat Oncol Biol Phys 2000 Dec 1;48(5):1359-62
|
|
|
Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff
RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier
A, Lacombe D, Stupp R
Nomograms for predicting survival of patients with newly diagnosed
glioblastoma: prognostic factor analysis of EORTC and NCIC trial
26981-22981/CE.3
Lancet Oncol. 2007 Dec 12; [Epub ahead of print]
Abstract |
Links | BL 7:1
|
|
T. Gorlia, R. Stupp, E. A.
Eisenhauer, R. O. Mirimanoff, M. J. Van Den Bent, K. Belanger, D. Lacombe, A.
Allgeier, European Organisation for Research and Treatment of Cancer (EORTC)
Brain And Radiotherapy Groups, National Cancer Institute of Canada (NCIC)
Clinical Trials Group
Clinical prognostic factors affecting survival in
patients with newly diagnosed Glioblastoma Multiforme (GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9599
|
|
Hakin-Smith
V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR,
Royds JA
Alternative
lengthening of telomeres and survival in patients with glioblastoma multiforme
Lancet 2003 Mar 8;361(9360):836-8
|
|
|
Hottinger AF, Yoon H, Deangelis LM, Abrey LE
Neurological
outcome of long-term glioblastoma survivors
J Neurooncol.
2009 Jun 26. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Hutterer M
Elderly Patients with Glioblastoma Multiforme - An Underestimated
Subpopulation?
Neuroepidemiology. 2009 Mar 27;33(1):23-24. [Epub ahead of print]°
Abstract |
Reprint |
Links |
Issue
|
|
|
Kawabata
S, Miyatake SI, Nonoguchi N, Hiramatsu R, Iida K, Miyata S, Yokoyama K, Doi
A, Kuroda Y, Kuroiwa T, Michiue H, Kumada H, Kirihata M, Imahori Y,
Maruhashi A, Sakurai Y, Suzuki M, Masunaga SI, Ono K
Survival benefit from boron neutron capture therapy for the newly diagnosed
glioblastoma patients
Appl Radiat Isot. 2009 Mar 25;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Kita
D, Ciernik IF, Vaccarella S, Franceschi S, Kleihues P, Lütolf UM, Ohgaki
H.
Age as a Predictive Factor in Glioblastomas: Population-Based Study
Neuroepidemiology. 2009 Mar 27;33(1):17-22. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Kong DS, Song SY, Kim DH, Joo KM, Yoo JS, Koh
JS, Dong SM, Suh YL, Lee JI, Park K, Kim JH, Nam DH
Prognostic significance of c-Met expression in glioblastomas
Cancer. 2008 Oct 30. [Epub
ahead of print]
Abstract |
Links |
Issue
|
|
|
Krex
D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M,
Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G; German Glioma
Network
Long-term survival with glioblastoma multiforme
Brain.
2007 Oct;130(Pt 10):2596-606. Epub 2007 Sep 4
Abstract
|
Full
Text |
Reprint
|
Links |
BL 7:16
|
|
|
Li S, Zhang W, Chen B, Jiang T, Wang Z
Prognostic and predictive value of p53 in low MGMT expressing
glioblastoma treated with surgery, radiation and adjuvant temozolomide
chemotherapy
Neurol Res.
2009 Aug 21. [Epub ahead of print]
Abstract |
Links |
CNO 8(10)
|
|
|
Li
SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, Jiang T
Prognostic factors influencing clinical outcomes of glioblastoma multiforme
Chin Med J (Engl). 2009 Jun 5;122(11):1245-9
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Li S, Jiang T, Li G, Wang Z
Impact of p53 status to response of temozolomide in low MGMT expression
glioblastomas: preliminary results
Neurol Res.
2008 Jul;30(6):567-70
Abstract |
Links |
BL 7:15
|
|
|
Matsuda
M, Yamamoto T, Kumada H, Nakai K, Shirakawa M, Tsurubuchi T, Matsumura A
Dose distribution and clinical response of glioblastoma treated with boron
neutron capture therapy
Appl Radiat Isot. 2009 Mar 27;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Matsumura
A, Yamamoto T, Tsurubuchi T, Matsuda M, Shirakawa M, Nakai K, Endo K, Tokuue
K, Tsuboi K.
Current practices and future directions of therapeutic strategy in
glioblastoma: Survival benefit and indication of BNCT
Appl Radiat Isot. 2009 Mar 24;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
McGirt MJ, Mukherjee D, Chaichana KL, Than KD,
Weingart JD, Quinones-Hinojosa A.
Association of surgically acquired motor and language deficits on overall
survival after resection of glioblastoma multiforme
Neurosurgery. 2009 Sep;65(3):463-9; discussion 469-70
Abstract |
Links |
Issue
|
|
|
McLendon
RE, Halperin EC
Is the long-term survival of patients with intracranial glioblastoma
multiforme overstated?
Cancer. 2003 Oct
15;98(8):1745-8. Published Online: 26 Aug 2003
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Mellai M, Caldera V, Annovazzi L, Chiò
A, Lanotte M, Cassoni P, Finocchiaro G, Schiffer D
MGMT Promoter Hypermethylation in a Series of 104 Glioblastomas
Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):219-27
Abstract |
Links |
Issue
|
|
|
Miyatake
SI, Kawabata S, Yokoyama K, Kuroiwa T, Michiue H, Sakurai Y, Kumada H,
Suzuki M, Maruhashi A, Kirihata M, Onoc K
Survival benefit of boron neutron capture therapy for recurrent malignant
gliomas
Appl Radiat Isot. 2009 Mar 27;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Monika E. Hegi, Ph.D.,
Annie-Claire Diserens, M.Sc., Thierry Gorlia, M.Sc., Marie-France Hamou,
Nicolas de Tribolet, M.D., Michael Weller, M.D., Johan M. Kros, M.D.,
Johannes A. Hainfellner, M.D., Warren Mason, M.D., Luigi Mariani, M.D.,
Jacoline E.C. Bromberg, M.D., Peter Hau, M.D., René O. Mirimanoff, M.D.,
J. Gregory Cairncross, M.D., Robert C. Janzer, M.D., and Roger Stupp, M.D.
MGMT
Gene Silencing and Benefit from Temozolomide in Glioblastoma
The New England Journal of Medicine,
Volume 352:997-1003, Number 10, March 10, 2005
|
|
Monika E. Hegi,
Annie-Claire Diserens, Sophie Godard,
Pierre-Yves Dietrich, Luca Regli,
Sandrine Ostermann, Philippe Otten,
Guy Van Melle, Nicolas de Tribolet
and Roger Stupp
Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA
Methyltransferase Promoter Methylation in Glioblastoma Patients
Treated with Temozolomide
Clinical Cancer Research Vol. 10, 1871-1874, 15 March 2004
|
|
|
Hulleman E, Quarto M, Vernell R, Masserdotti G,
Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Rodriguez Y
Baena R, Capra M, Helin K.
A role for the transcription factor HEY1 in glioblastoma
J Cell Mol Med. 2008 Mar 17; [Epub ahead of print]
Abstract |
Reprint |
Links | BL 7:7
|
|
Keles GE, Lamborn KR, Chang SM, Prados
MD, Berger MS
Volume of residual disease as a predictor of
outcome in adult patients with recurrent supratentorial glioblastomas
multiforme who are undergoing chemotherapy
J Neurosurg. 2004 Jan;100(1):41-6
|
|
B. K. Kleinschmidt-DeMasters, MD; K. O.
Lillehei, MD; M. Varella-Garcia, PhD
Glioblastomas in the Older
Old
Arch
Pathol Lab Med. 2005 May;129(5):624-631
|
|
Koka V, Potti A, Forseen SE, Pervez H,
Fraiman GN, Koch M, Levitt R
Role
of her-2/neu overexpression and clinical determinants of early mortality
in glioblastoma multiforme
Am J Clin Oncol.
2003 Aug;26(4):332-5
|
|
H. Kobayashi, N. Ishii, J. Ikeda,
Y. Sawamura, Y. Iwasaki
Methylation
profiling of the DNA repair genes in glioblastoma multiforme and its clinical
relevance
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1572
|
|
Kraus JA,
Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete
S, Dietzmann K, Muller B, Heuser K, Reifenberger G, Schlegel U
Long-term
survival of glioblastoma multiforme: importance of histopathological
reevaluation
J Neurol. 2000
Jun;247(6):455-60
|
|
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F,
Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller
D, Sawaya R
A
multivariate analysis of 416 patients with glioblastoma multiforme:
prognosis, extent of resection, and survival
J Neurosurg. 2001
Aug;95(2):190-8
|
|
Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados
Prognostic factors for survival of patients with glioblastoma: Recursive
partitioning analysis
Neuro-Oncology, Vol. 6, No. 3, July
2004, 227 -- 235. (Abstract+)
|
|
|
Leif G. Salford, Erik Nordenström, Gunnar Skagerberg, Torgil Möller,
Bengt Widegren, and Roland Perfekt
Women with Left Frontal Glioblastoma Have a Significantly Shorter
Survival—Why?
Neuro-oncol 2006; 8(4): 290-291; first published on August 31, 2006 as DOI:
10.1215/15228517-2006-017
Full
Text |
Reprint
|
|
|
Daniel A. Lim, Soonmee Cha,
Mary C. Mayo, Mei-Hsiu Chen, Evren Keles,
Scott VandenBerg and Mitchel S. Berger
Relationship of glioblastoma multiforme to neural stem cell regions
predicts invasive and multifocal tumor phenotype
Neuro Oncol 2007 Oct 1. 9(4):424-429; DOI:10.1215/15228517-2007-023. First
published on July 10, 2007
Abstract
|
Full
Text |
Reprint
|
Links | BL 7:2
|
|
Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN,
Wildrick DM, Sawaya R
Cystic glioblastoma multiforme: survival outcomes in
22 cases
J Neurosurg. 2004 Jan;100(1):61-7
|
|
|
Mangiola A, de Bonis P, Maira G, Balducci M,
Sica G, Lama G, Lauriola L, Anile C
Invasive tumor cells and prognosis in a selected population of patients
with glioblastoma multiforme
Cancer. 2008 Jul 10; [Epub ahead of print]
Abstract |
Links |
BL 7:14
|
|
|
Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C,
Lauriola L, La Torre G, Sabatino G, Maira G, Jhanwar-Uniyal M, Sica G
Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and
Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications
Clin
Cancer Res. 2007 Dec 1;13(23):6970-6977.
Abstract |
Links
|
|
|
Marchan EM, Sekula RF Jr, Jannetta PJ, Quigley
MR
Long-term survival enhanced by cordectomy in a patient with a spinal
glioblastoma multiforme and paraplegia. Case report
J Neurosurg Spine. 2007 Dec;7(6):656-9
Abstract |
Links | BL 7:1
|
|
|
McLendon
RE, Halperin EC
Is the long-term survival of patients with intracranial glioblastoma
multiforme overstated?
Cancer. 2003 Oct
15;98(8):1745-8. Published Online: 26 Aug 2003
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Ramon Martinez, Gabriele Schackert and
Manel Esteller
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic
importance in glioblastoma multiforme
J Neurooncol. 2006 Oct 18; [Epub
ahead of print]
Abstract
|
|
|
Park
CK, Park SH, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung
HW
Methylation status of the MGMT gene promoter fails to predict the clinical
outcome of glioblastoma patients treated with ACNU plus cisplatin
Neuropathology. 2009 Jan 6. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R,
Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ.
Tumor regrowth between surgery and initiation of adjuvant therapy in
patients with newly diagnosed glioblastoma
Neuro Oncol. 2009 Feb 19; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Puzzilli
F, Ruggeri A, Mastronardi L, Di Stefano D, Lunardi P
Long-term survival in cerebral glioblastoma. Case report and critical
review of the literature
Tumori. 1998 Jan-Feb;84(1):69-74
Abstract |
Links |
Issue
|
|
|
Mauer
M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, de Witte O,
Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller
M, Bottomley A.
The prognostic value of health-related quality-of-life data in predicting
survival in glioblastoma cancer patients: results from an international
randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and
NCIC Clinical Trials Group study.
Br J Cancer.
2007 Jul 3; [Epub ahead of print]
PMID: 17609661 [PubMed - as supplied by publisher]
|
|
Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS,
Chang SM
Prognostic significance of intracranial dissemination of
glioblastoma multiforme in adults
J
Neurosurg. 2005 Apr;102(4):622-8
|
|
|
Pichlmeier U, Bink A, Schackert G, Stummer W,
Study Group AG.
Resection and survival in glioblastoma multiforme: An RTOG recursive
partitioning analysis of ALA study patients
Neuro Oncol. 2008 Jul 30; [Epub ahead of print]
Abstract |
Links |
BL 7:16
|
|
|
Ruano Y, Mollejo M, Camacho FI, de Lope AR, Fiaño
C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B
Identification of survival-related genes of the phosphatidylinositol
3'-kinase signaling pathway in glioblastoma multiforme
Cancer. 2008 Feb 7; [Epub
ahead of print]
Abstract |
Links | BL 7:4
|
|
|
Ruano Y, Ribalta T, de Lope AR, Campos-Martín
Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B
Worse outcome in primary glioblastoma multiforme with concurrent epidermal
growth factor receptor and p53 alteration
Am J Clin Pathol. 2009 Feb;131(2):257-63
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F,
Arifin MT, Arita K, Kurisu K.
Prognosis of cerebellar glioblastomas: correlation between prognosis and
immunoreactivity for epidermal growth factor receptor compared with
supratentorial glioblastomas.
Anticancer Res. 2006
Mar-Apr;26(2B):1351-7.
Abstract
|
|
|
Salvati
M, Formichella AI, D'Elia A, Brogna C, Frati A, Giangaspero F, Delfini R,
Santoro A
Cerebral
glioblastoma with oligodendrogliomal component: analysis of 36 cases
J Neurooncol.
2009 Apr 3. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Salvati
M, Cervoni L, Artico M, Caruso R, Gagliardi FM
Long-term survival in patients with supratentorial glioblastoma
J Neurooncol.
1998 Jan;36(1):61-4
Abstract |
Reprint
|
Links |
Issue
|
|
|
Saraswathy S, Crawford FW, Lamborn KR, Pirzkall
A, Chang S, Cha S, Nelson SJ.
Evaluation of MR markers that predict survival in patients with newly
diagnosed GBM prior to adjuvant therapy
J Neurooncol. 2008 Sep 23; [Epub ahead of print]
Abstract |
Links |
BL 7:19
|
|
Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA,
Hamilton M, Cairncross JG, Forsyth P
Which
glioblastoma multiforme patient will become a long-term survivor? A
population-based study
Ann Neurol. 1999 Aug;46(2):183-8
|
|
Scott JN,
Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, Sutherland G,
Cairncross JG, Forsyth P
Long-term
glioblastoma multiforme survivors: a population-based study
Can J Neurol Sci. 1998 Aug;25(3):197-201
|
|
|
Schaich M, Kestel L, Pfirrmann M, Robel K,
Illmer T, Kramer M, Dill C, Ehninger G, Schackert G, Krex D.
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of
temozolomide treatment in glioblastoma patients
Ann Oncol. 2008 Aug 7; [Epub ahead of print]
Abstract |
Links |
BL 7:16
|
|
|
Scheurer ME, Amirian E, Cao Y, Gilbert MR,
Aldape KD, Kornguth DG, El-Zein R, Bondy ML
Polymorphisms in the interleukin-4 receptor gene are associated with
better survival in patients with glioblastoma
Clin Cancer Res. 2008 Oct 15;14(20):6640-6
Abstract |
Links |
Issue
|
|
|
Schoenegger
K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D, Heinzl H,
Lahrmann H, Marosi C, Grisold W.
Peritumoral edema on MRI at initial diagnosis: an independent prognostic
factor for glioblastoma?
Eur J Neurol. 2009 Apr 10;. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Senger
D, Cairncross JG, Forsyth PA
Long-term survivors of glioblastoma: statistical aberration or important
unrecognized molecular subtype?
Cancer J.
2003 May-Jun;9(3):214-21
Abstract |
Links |
Issue
|
|
A.
Shet, A. E. Schorer, M. A. Kuskowski
Venous
thromboembolism is common but does not alter survival in glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
432
|
|
Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada
K, Kuratsu J, Ishimaru Y, Ushio Y
The influence of sex and the presence of giant cells on
postoperative long-term survival in adult patients with supratentorial
glioblastoma multiforme
J Neurosurg. 2004 Aug;101(2):219-26
|
|
|
Shirai K, Suzuki Y, Oka K, Noda SE, Katoh H,
Suzuki Y, Itoh J, Itoh H, Ishiuchi S, Sakurai H, Hasegawa M, Nakano T
Nuclear survivin expression predicts poorer prognosis in glioblastoma
J Neurooncol.
2008 Oct 25. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Shnaper S, Desbaillets I, Brown DA, Murat A,
Migliavacca E, Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de
Tribolet N, Hegi ME
Elevated
levels of MIC-1/ GDF15 in the cerebro-spinal fluid (CSF) of patients are
associated with glioblastoma and worse outcome
Int
J Cancer. 2009 Jun 11. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Simon, Matthias M.D.; Ludwig, Michael Ph.D.; Fimmers, Rolf Ph.D.; Mahlberg,
Ralph; Muller-Erkwoh, Angelika M.D.; Koster, Gertraud Ph.D.; Schramm, Johannes
M.D.
Variant Of The Chek2 Gene As A Prognostic Marker In Glioblastoma Multiforme.
Clinicopathological Study
Neurosurgery. 2006 Sep 28; [Epub ahead of
print]
Abstract
|
|
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P,
Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, et al
Influence of location and
extent of surgical resection on survival of patients with glioblastoma
multiforme: results of three consecutive Radiation Therapy Oncology Group
(RTOG) clinical trials
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44
|
|
|
Sorensen AG, Batchelor TT, Zhang WT, Chen PJ,
Yeo P, Wang M, Jennings D, Wen PY, Lahdenranta J, Ancukiewicz M, di Tomaso
E, Duda DG, Jain RK
A
"vascular normalization index" as potential mechanistic biomarker
to predict survival after a single dose of cediranib in recurrent
glioblastoma patients
Cancer Res. 2009
Jul 1;69(13):5296-300. Epub 2009 Jun 23
Abstract |
Links |
Issue
|
|
|
Spence
AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC,
Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA.
Regional Hypoxia in Glioblastoma Multiforme Quantified with
[18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy:
Correlation with Time to Progression and Survival
Clin
Cancer Res. 2008 May 1;14(9):2623-30
Abstract |
Links | BL 7:10
|
|
|
Sperduto
CM, Chakravarti A, Aldape K, Burger P, Papermaster GB, Sperduto P.
Twenty-Year Survival In Glioblastoma: A Case Report And Molecular Profile
Int J Radiat Oncol Biol Phys. 2009 Mar 25. [Epub ahead of print]°
Abstract |
Links |
Issue
|
|
|
Stupp
R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK,
Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C,
Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller
M, Lacombe D, Cairncross JG, Mirimanoff RO
Effects of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised phase III
study: 5-year analysis of the EORTC-NCIC trial
Lancet Oncol. 2009 Mar 6;. [Epub ahead of print]°
Abstract |
Links |
Issue
|
|
|
Swanson KR, Rostomily RC, Alvord EC Jr
A mathematical modelling tool for predicting survival of individual
patients following resection of glioblastoma: a proof of principle
Br J Cancer. 2007 Dec 4;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
Links | BL 7:1
|
|
|
Tibbetts
KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR.
Histopathologic predictors of pilocytic astrocytoma event-free survival
Acta Neuropathol. 2009 Mar 7;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Tramacere
F, Gianicolo E, Serinelli M, Bambace S, De Luca M, Castagna R, Francavilla
MC, Leone A, Monastero S, Fucilli F, Pili G, Distante A, Portaluri M.
Multivariate analysis of prognostic factors and survival inpatients with
"glioblastoma multiforme"
Clin Ter. 2008 Jul-Aug;159(4):233-238
Abstract |
Links | BL 7:18
|
|
|
Wang LF, Fokas E, Juricko J, You A, Rose F,
Pagenstecher A, Engenhart-Cabillic R, An HX.
Increased expression of EphA7 correlates with adverse outcome in primary
and recurrent glioblastoma multiforme patients
BMC Cancer. 2008 Mar 25;8(1):79
Abstract |
Full Text |
Reprint |
Links | BL 7:7
|
|
|
Welsh JW, Ellsworth RK, Kumar R, Fjerstad K,
Martinez J, Nagel RB, Eschbacher J, Stea B
Rad51
protein expression and survival in patients with glioblastoma multiforme
Int
J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1251-5
Abstract |
Links |
Issue
|
|
|
Gliomas
|
|
|
|
|
Basso U, Monfardini S, Brandes AA
Recommendations for the
management of malignant gliomas in the elderly
Expert Rev Anticancer Ther. 2003 Oct;3(5):643-54
|
|
Batistatou A, Kyzas PA, Goussia A, Arkoumani E,
Voulgaris S, Polyzoidis K, Agnantis NJ, Stefanou D.
Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and
prognosis in brain glial tumours.
J Neurooncol. 2006 Mar;77(1):17-23. Epub 2005 Nov 15.
Abstract
|
|
|
Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z
Cerebral
Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready
for the Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
AJNR
Am J Neuroradiol. 2009 Jan 29. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
P. D. Brown, K. V. Ballman, T. A.
Rummans, M. J. Maurer, J. A. Sloan, B. F. Boeve, R. M. Arusell, M. M. Clark, J.
C. Buckner
Prospective NCCTG quality of life (QOL)
study in adult newly diagnosed high-grade gliomas (HGG)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1524
|
| |
Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown
CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG
Importance
of baseline mini-mental state examination as a prognostic factor for patients
with low-grade glioma
Int J Radiat Oncol Biol Phys. 2004
May 1;59(1):117-25
|
|
Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, Rorke L,
Sutton LN, Phillips PC, Shu HK
Near complete surgical resection predicts a favorable outcome
in pediatric patients with nonbrainstem, malignant gliomas: results from a
single center in the magnetic resonance imaging era
Cancer. 2004 Aug 15;101(4):817-24
|
| |
Buckner JC
Factors influencing survival in high-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4
|
|
J.
C. Buckner, B. W. Scheithauer, J. R. O'Fallon, P. Schaefer, C. Giannini, K.
Ballman, R. Jenkins
p53, EGFR, and PTEN as markers of diagnosis and
prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
393
|
| |
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken
R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival
prediction in high-grade gliomas by MRI perfusion before and during early stage
of RT
Int
J Radiat Oncol Biol Phys. 2005 Nov 17;
[Epub ahead of print]
|
|
K. Carson, S. A. Grossman,
J. D. Fisher and E. Shaw
Prognostic factors for survival in
adult patients with recurrent glioma enrolled on New Approaches to Brain Tumor
Therapy (NABTT) CNS Consortium phase I and II clinical trials
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1509
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1509
|
|
WJ Curran Jr, CB Scott, J Horton, JS Nelson, AS Weinstein, AJ
Fischbach, CH Chang, M Rotman, SO Asbell and RE Krisch
Recursive partitioning analysis of prognostic factors in three Radiation
Therapy Oncology Group malignant glioma trials
Journal Of The National Cancer Institute, Volume 85, Issue 9 :
May 5, 1993, 704-710
|
|
Curran WJ
Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K,
Fischbach AJ, Yakar D, Schwade JG, et al.
Survival
comparison of radiosurgery-eligible and -ineligible malignant glioma patients
treated with hyperfractionated radiation therapy and carmustine: a report of
Radiation Therapy Oncology Group 83-02
J Clin Oncol. 1993 May;11(5):857-62
|
| |
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S
Positron emission tomography with
injection of methionine as a prognostic factor in glioma
J
Neurosurg. 2001 Nov;95(5):746-50)
|
|
A.
Flowers
Management of malignant
gliomas at Hartford Hospital: Patterns of care and outcomes
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
464)
|
| |
E.
Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo,
J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response
assessment in gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor
area vs volume
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
423
|
|
|
Gennadi V. Glinsky, Olga
Berezovska and Anna B. Glinskii
Microarray analysis identifies a death-from-cancer signature predicting
therapy failure in patients with multiple types of cancer
J. Clin. Invest. 115:1503-1521 (1 June 2005)
Abstract
|
Full
Text |
Reprint
|
|
|
Gupta
T, Sarin R, Jalali R, Sharma S, Kurkure P, Goel A
A pragmatic clinicopathobiological grouping/staging system for gliomas:
Proposal of the Indian TNM subcommittee on brain tumors
Neurol India. 2009 May-Jun;57(3):247-51
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Halperin EC
Malignant gliomas in older
adults with poor prognostic signs. Getting nowhere, and taking a long time
to do it
Oncology (Huntingt). 1995 Mar;9(3):229-34; discussion 237-8, 243
|
|
Huncharek
M, Muscat J
Treatment
of recurrent high grade astrocytoma; results of a systematic review of 1,415
patients
Anticancer Res. 1998 Mar-Apr; 18(2B): 1303-11
|
|
Yasushi
Ino,
M.D., Magdalena
C. Zlatescu,
M.D., Hikaru
Sasaki,
M.D., Ph.D.,
David
R. Macdonald,
M.D., Anat
O. Stemmer-Rachamimov,
M.D., Sarah
Jhung,
B.S., David
A. Ramsay,
M.D., Andreas
Von Deimling,
M.D., David
N. Louis,
M.D., And
J. Gregory
Cairncross,
M.D.
Long
survival and therapeutic responses in patients with histologically
disparate high-grade gliomas demonstrating chromosome 1p loss
J Neurosurg.,
92:983–990, June 2000
|
|
|
Iwamoto FM, Nicolardi L, Demopoulos A,
Barbashina V, Salazar P, Rosenblum M, Hormigo A.
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2
and 3 gliomas
J Neurooncol.
2008 Mar 15; [Epub ahead of print]
Abstract |
Links | BL 7:7
|
|
Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic
J, Nikolic N
Clinical prognostic factors in patients with
malignant glioma treated with combined modality approach
Am J Clin Oncol. 2004 Apr;27(2):195-204
|
|
Klein M,
Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, Van Der Ploeg HM,
Heimans JJ
The
prognostic value of cognitive functioning in the survival of patients with
high-grade glioma
Neurology. 2003 Dec 23;61(12):1796-8
|
| |
Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R,
Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76
|
|
B. E. Lally, J. M. Colasanto,
J. P. S. Knisely
The prognostic effect of hemoglobin levels on
survival for patients with high-grade gliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1565)
|
|
Laws ER, Parney IF, Huang W, Anderson F, Morris AM,
Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S;
Glioma Outcomes Investigators
Survival following surgery
and prognostic factors for recently diagnosed malignant glioma: data from
the Glioma Outcomes Project
J Neurosurg. 2003 Sep;99(3):467-73
|
|
Ljubimova JY, Fugita M, Khazenzon NM, Das A, Pikul BB, Newman D, Sekiguchi K,
Sorokin LM, Sasaki T, Black KL
Association between laminin-8 and glial tumor grade,
recurrence, and patient survival
Cancer. 2004 Aug 1;101(3):604-12
|
|
|
Law
M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC,
Golfinos JG, Zagzag D, Johnson G.
Gliomas: predicting time to progression or survival with cerebral blood
volume measurements at dynamic susceptibility-weighted contrast-enhanced
perfusion MR imaging
Radiology. 2008 May;247(2):490-8.
Epub 2008 Mar 18
Abstract |
News |
Links | BL 7:10
|
|
Murovic
J, Turowski K, Wilson CB, Hoshino T, Levin V
Computerized
tomography in the prognosis of malignant cerebral gliomas
J
Neurosurg 1986 Dec;65(6):799-806
|
|
Satoshi
Nakasu, Tadateru Fukami, Kazumi Baba, Masayuki Matsuda
Immunohistochemical
study for O6-methylguanine-DNA methyltransferase in the
non-neoplastic and neoplastic components of gliomas
Journal
of Neuro-Oncology, 70(3):
333-340, December 2004. (Abstract+)
|
| |
Nieder C, Grosu AL, Molls M
A
comparison of treatment results for recurrent malignant gliomas
Cancer Treat Rev. 2000 Dec; 26(6): 397-409
|
|
M.V. Padma, S. Said,
M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T.
Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003
|
|
Ian F. Pollack, Ronald
L. Hamilton, Robert W. Sobol, Judith Burnham,
Allan J. Yates, Emiko J. Holmes, Tianni
Zhou, Jonathan L. Finlay
O6-Methylguanine-DNA
Methyltransferase Expression Strongly Correlates With Outcome in Childhood
Malignant Gliomas: Results From the CCG-945 Cohort
Journal of Clinical Oncology, Vol 24, No 21 (July 20), 2006: pp. 3431-3437;
DOI: 10.1200/JCO.2006.05.7265
|
|
R.
D. Rao, R. Jenkins, B. W. Scheithauer, J. R. O'Fallon, A. Furth, A.
Furth, N. Iturria, P. Schaefer, J. C. Buckner
Correlations
between cytological subtypes and cytogenetic aberrations in high grade
gliomas
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
422
|
|
S.
N. Raval, B. Gu, J. J. Raizer, M. K. Rosenblum, D. Banerjee, J. R.
Bertino, L. M. DeAngelis
Methylation of MGMT promotor, the DNA repair gene
as an independent prognostic factor for malignant glioma
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
452
|
|
|
Russell
SM, Elliott R, Forshaw D, Golfinos JG, Nelson PK, Kelly PJ
Glioma
vascularity correlates with reduced patient survival and increased
malignancy
Surg Neurol. 2009 Mar 27. [Epub
ahead of print]
Abstract |
Links |
Issue
|
|
Andrea Salmaggi, Marica Eoli, Simona Frigerio, Antonio
Silvani, Maurizio Gelati, Elena Corsini, Giovanni Broggi, Amerigo Boiardi
Intracavitary
VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
Journal of Neuro-Oncology,
62 (3): 297-303, May
2003
|
|
Shono T,
Tofilon PJ, Bruner JM, Owolabi O, Lang FF
Cyclooxygenase-2
expression in human gliomas: prognostic significance and molecular correlations
Cancer Res 2001 Jun 1;61(11):4375-81
|
|
|
Sanai
N, Berger MS.
Glioma extent of resection and its impact on patient outcome
Neurosurgery. 2008
Apr;62(4):753-64
Abstract |
Full
Text |
Reprint
|
Links | BL 7:11
|
|
Stewart LA
Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of individual
patient data from 12 randomised trials
Lancet. 2002 Mar 23;359(9311):1011-8
|
| |
Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO
Prognostic factors for low-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8
|
|
Takahashi Y,
Imahori Y, Mineura K
Prognostic
and therapeutic indicator of fluoroboronophenylalanine positron emission
tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95
|
|
Avelina
Tortosa, Nuria Vinolas, Salvador Villa, Eugenia Verger, Juan M Gil, Marta Brell,
Lluis Caral, Teresa Pujol, Juan Jose Acebes, Teresa Ribalta, Isidre Ferrer,
Francesc Graus
Prognostic
implication of clinical, radiological, and pathological features in patients
with anaplastic glioma
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
304
|
|
Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J
Debulking or biopsy of
malignant glioma in elderly people - a randomised study
Acta Neurochir (Wien). 2003 Jan;145(1):5-10
|
|
J.
H. Wisoff, A. Sanford, E. Holmes, R. Sposto, L. Kun, L. Heier, P.
Burger, A. Yates
Impact of
surgical resection on low grade gliomas of childhood: A report from the
CCG9891/POG9130 low grade astrocytoma study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
401
|
|
Wong
ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung
WK
Outcomes
and prognostic factors in recurrent glioma patients enrolled onto phase II
clinical trials
J Clin Oncol. 1999 Aug;17(8):2572
|
|
|
Zeppernick F, Ahmadi R, Campos B, Dictus C,
Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Clin Cancer Res. 2008 Jan 1;14(1):123-9
Abstract |
Links |
BL 7:2
|
|
Yi-Hong Zhou, Kenneth R. Hess, W. K. Alfred
Yung
Prognostic model for glioma patients
Proceedings of the AACR, Volume 45, March 2004, Abstract
Number: 1078
|
|
Yi-Hong Zhou, Fang Tan, Kenneth R. Hess
and W. K. Alfred Yung
The Expression of PAX6, PTEN, Vascular Endothelial Growth Factor, and
Epidermal Growth Factor Receptor in Gliomas. Relationship to Tumor Grade and Survival
Clinical Cancer Research Vol. 9, 3369-3375, August 2003
|
|
Brainstem
Gliomas |
|
|
|
Kesari
S, Kim RS, Markos V, Drappatz J, Wen PY, Pruitt AA
Prognostic factors in adult brainstem gliomas: a multicenter, retrospective
analysis of 101 cases
J Neurooncol.
2008 Mar 26; [Epub ahead of print]
Abstract |
Links | BL 7:8
|
|
Primary
Spinal Gliomas |
|
|
Jen-Ho Tseng, Ming-Yuan Tseng
Survival Analysis of 81 Children with Primary
Spinal Gliomas: A Population-Based Study
Pediatr Neurosurg. 2006 Oct;42(6):347-53.
Abstract
|
|
|
Gliomas
(High Grade)
|
|
|
|
|
Fadime Akman, Rachel A. Cooper, Mehmet Şen,
Yildiray Tanriver, Süleyman Kentli
Validation of the Medical Research Council and A Newly Developed Prognostic
Index in Patients with Malignant Glioma:
How useful are Prognostic Indices in
Routine Clinical Practice?
Journal of Neuro-Oncology, 59 (1): 39-47, August 2002
Abstract |
Reprint |
Links | BL
1:3
|
|
Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Saito
T, Matsuura S, Yamasaki F, Arita K, Kurisu K.
Cytoplasmic, but not nuclear, p16 expression
may signal poor prognosis in high-grade astrocytomas.
J
Neurooncol. 2006 May;77(3):273-7. Epub
2006 Apr 14.
Abstract
|
|
|
Barnholtz-Sloan
JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan
AE
Patterns of care and outcomes among elderly individuals with primary
malignant astrocytoma
J Neurosurg. 2008 Apr;108(4):642-648
Abstract |
Full Text |
Reprint |
Links | BL 7:8
|
|
Paul D. Brown, Ashley
W. Jensen, Sara J. Felten, Karla V. Ballman, Paul
L. Schaefer, Kurt A. Jaeckle, Jane H. Cerhan, Jan
C. Buckner
Detrimental Effects of Tumor Progression on
Cognitive Function of Patients With High-Grade Glioma
Journal of Clinical Oncology, Vol 24, No 34 (December 1), 2006: pp.
5427-5433.
DOI: 10.1200/JCO.2006.08.5605
|
|
|
Burnet NG, Lynch AG, Jefferies SJ, Price SJ,
Jones PH, Antoun NM, Xuereb JH, Pohl U.
High grade glioma: Imaging combined with pathological grade defines
management and predicts prognosis
Radiother
Oncol. 2007 Nov 26; [Epub ahead of print]
Abstract |
Links
|
|
Dehais C, Laigle-Donadey F, Marie Y, Kujas M,
Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J,
Delattre JY, Sanson M.
Prognostic stratification of patients with anaplastic gliomas according to
genetic profile.
Cancer. 2006 Sep 19; [Epub ahead of print]
Abstract
|
|
|
Antje Ernst-Stecken, Oliver Ganslandt,
Ulrike Lambrecht, Rolf Sauer and Gerhard Grabenbauer
Survival and quality of life after hypofractionated stereotactic
radiotherapy for recurrent malignant glioma
J Neurooncol. 2006 Sep 20;
[Epub ahead of print]
Abstract
|
|
|
Adília Hormigo, Bin Gu,
Sasan Karimi, Elyn Riedel, Katherine S.
Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti
S. Rao, Martin Fleisher, Lisa M. DeAngelis
and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for
Patients with High-Grade Gliomas
Clin
Cancer Res. 2006 Oct 1;12(19):5698-704.
|
|
|
Laks
DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH,
Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S,
Kornblum HI
Neurosphere formation is an independent predictor of clinical outcome in
malignant glioma
Stem Cells. 2009 Apr;27(4):980-7
Abstract |
Links |
Issue
|
|
|
Lin
Y, Jiang T, Zhou K, Xu L, Chen B, Li G, Qiu X, Jiang T, Zhang W, Song SW
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade
gliomas
Neuro Oncol. 2009 Jan 22. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Lorenzoni
J, Torrico A, Villanueva P, Gederlini A, Torrealba G
Surgery for high-grade gliomas in a developing country: survival estimation
using a simple stratification system
Surg Neurol. 2008 Apr 25; [Epub ahead of print]
Abstract |
Links | BL 7:9
|
|
|
Martinez
R, Janka M, Soldner F, Behr R.
Gross-total Resection of Malignant Gliomas in Elderly
Patients: Implications in Survival.
Zentralbl
Neurochir. 2007 Oct 26; [Epub ahead of print]
Abstract
|
|
|
McGirt MJ, Chaichana KL, Gathinji M, Attenello
FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa A
Independent association of extent of resection with survival in patients
with malignant brain astrocytoma
J Neurosurg. 2008 Oct 10; [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Park
CK, Lee SH, Han JH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
Recursive partitioning analysis of prognostic factors in WHO grade III
glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
BMC Cancer. 2009 Dec 18;9(1):450. [Epub ahead of print]
Abstract |
Reprint |
Links |
CNO 9(1)
|
|
|
Ritz
R, Müller M, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M
Hypericin uptake: A prognostic marker for survival in high-grade glioma
J Clin Neurosci. 2008 Apr 3;. [Epub ahead of print]
Abstract |
Links | BL 7:8
|
|
|
Zhu YJ, Zhu XD, Wang SH, Shen F, Shen H, Liu WG.
A multivariate analysis of the prognostic factors of grade III gliomas
Chin Med J (Engl). 2008 Jun 20;121(12):1072-5
Abstract |
Full Text |
Reprint |
Links | BL 7:17
|
|
|
Gliomas
(Low Grade)
|
|
|
|
|
Bauman
G, Fisher B, Watling C, Cairncross JG, Macdonald D
Adult
Supratentorial Low-Grade Glioma: Long-Term Experience at a Single
Institution
Int
J Radiat Oncol Biol Phys. 2009 Apr 21. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
J. C. Buckner, K. V. Ballman, B. W.
Scheithauer, R. M. Arusell, H. E. Blair, S. M. Passe, P. D. Brown, K. A.
Jaeckle, E. G. Shaw, R. B. Jenkins
NCCTG 94-72-53: Diagnostic and
prognostic significance of 1p and 19q deletions in patients (pts) with low-grade
oligodendroglioma and astrocytoma
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1502
Journal
of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005: 1502
|
|
|
Chaichana KL, McGirt MJ, Woodworth GF, Datoo G,
Tamargo RJ, Weingart J, Olivi A, Brem H, Quinones-Hinojosa A
Persistent
outpatient hyperglycemia is independently associated with survival,
recurrence and malignant degeneration following surgery for hemispheric low
grade gliomas
Neurol Res.
2009 Jul 8. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Chaichana
KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A
Recurrence
and malignant degeneration after resection of adult hemispheric low-grade
gliomas
J Neurosurg.
2009 Apr 10. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A
Prognostic
significance of contrast-enhancing low-grade gliomas in adults and a review
of the literature
Neurol Res.
2009 Feb 12. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Chang EF, Clark A, Jensen RL, Bernstein M, Guha
A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger
MS, McDermott MW
Multiinstitutional
validation of the University of California at San Francisco Low-Grade Glioma
Prognostic Scoring System
J Neurosurg.
2009 Mar 6. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Chang EF, Smith JS, Chang SM, Lamborn KR, Prados
MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM
Preoperative prognostic classification system for hemispheric low-grade
gliomas in adults
J Neurosurg.
2008 Nov;109(5):817-24
Abstract |
Links |
Issue
|
|
EJ Dropcho and SJ Soong
The prognostic impact of prior low
grade histology in patients with anaplastic gliomas: a case-control study
Neurology, Vol 47, Issue 3 684-690, September 1 1996
|
|
|
Hattingen E, Raab P, Franz K, Lanfermann H,
Setzer M, Gerlach R, Zanella FE, Pilatus U
Prognostic value of choline and creatine in WHO grade II gliomas
Neuroradiology. 2008
Jun 4. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links | BL 7:12
|
|
Karim
AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S,
Pierart M, Van Glabbeke M
Randomized
trial on the efficacy of radiotherapy for cerebral low-grade glioma in the
adult: European Organization for Research and Treatment of Cancer Study 22845
with the Medical Research Council study BRO4: an interim analysis
Int
J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24
|
|
Karim
AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F,
Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers
HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M
A randomized trial on dose-response
in radiation therapy of low-grade cerebral glioma: European Organization for
Research and Treatment of Cancer (EORTC) Study 22844
Int
J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56
|
|
Kujas M, Lejeune J, Benouaich-Amiel A, Criniere
E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka
M, Bernier M, Chretien F, Couvelard A, Capelle
L, Duffau H, Cornu P, Broet P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K,
Delattre
JY.
Chromosome 1p loss: A favorable
prognostic factor in low-grade gliomas
Ann Neurol. 2005 Jul 27;58(2):322-326
[Epub ahead of print].
|
|
C. Lebrun, MD, D.
Fontaine, MD, A. Ramaioli, PhD, F. Vandenbos, MD,
S. Chanalet, MD, M. Lonjon, MD PhD, J. F.
Michiels, MD PhD, V. Bourg, MD, P. Paquis, MD PhD,
M. Chatel, MD, M. Frenay, MD and The Nice Brain
Tumor Study Group
Long-term outcome of
oligodendrogliomas
Neurology, 62:1783-1787; 25 May 2004
|
|
|
Mariani L, Deiana G, Vassella E, Fathi AR, Murtin
C, Arnold M, Vajtai I, Weis J, Siegenthaler P, Schobesberger M, Reinert MM.
Loss of Heterozygosity 1p36 and 19q13 Is a
Prognostic Factor for Overall Survival in Patients With Diffuse WHO Grade 2
Gliomas Treated Without Chemotherapy.
J
Clin Oncol. 2006 Sep 11; [Epub
ahead of print]
Abstract
|
|
|
Law, Meng M.D.; Oh, Sarah M.D.; Johnson, Glyn
Ph.D.; Babb, James S. Ph.D.; Zagzag, David M.D., Ph.D.; Golfinos, John M.D.;
Kelly, Patrick J. M.D.
Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an
Adjunct to Histopathology: A Second Reference Standard in the Surgical and
Nonsurgical Treatment of Low-grade Gliomas
Neurosurgery. 58(6):1099-1107, June 2006
Abstract
| Full
Text |
Reprint
|
|
|
Nakasu S, Fukami T, Jito J, Matsuda M
Prognostic significance of loss of O6-methylguanine-DNA methyltransferase
expression in supratentorial diffuse low-grade astrocytoma
Surg Neurol.
2007 Dec;68(6):603-8;
discussion 608-9. Epub 2007 Sep 10
Abstract |
Links | BL 7:4
|
| |
Nuutinen
J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E,
Norrgard S, Kulmala J, Teras M, Minn H
Radiotherapy
treatment planning and long-term follow-up with [(11)C]methionine PET
in patients with low-grade astrocytoma
Int
J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52
|
|
Jon D. Olson, MD, Elyn
Riedel, MA and Lisa M. DeAngelis, MD
Long-term outcome of low-grade
oligodendroglioma and mixed glioma
Neurology 54:1442-1448; 11 April
2000. (Abstract+)
|
|
Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin
R, Galanaud D, Taillandier L, Capelle L.
Prognostic value of initial magnetic resonance imaging growth rates for World
Health Organization grade II gliomas.
Ann Neurol. 2006 Sep 18;60(3):380-383 [Epub ahead of print]
Abstract
|
|
Francesco Pignatti, Martin
van den Bent, Desmond Curran, Channa
Debruyne, Richard Sylvester, Patrick
Therasse, Denes Áfra, Philippe Cornu,
Michel Bolla, Charles Vecht, Abul
B.M.F. Karim for the European Organization for Research and
Treatment of Cancer Brain Tumor Cooperative Group and Radiotherapy
Cooperative Group
Prognostic Factors for Survival in
Adult Patients With Cerebral Low-Grade Glioma
Journal of Clinical Oncology, Vol 20,
Issue 8 (April), 2002: 2076-2084. (Abstract+)
|
|
Ribom
D, Engler H, Blomquist E, Smits A
Potential
significance of (11)C-methionine PET as a marker for the radiosensitivity of
low-grade gliomas
Eur
J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5
|
|
Ribom
D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H,
Bergstrom M, Smits A
Positron
emission tomography (11)C-methionine and survival in patients with low-grade
gliomas
Cancer.
2001 Sep 15;92(6):1541-9
|
|
Ribom
D, Adner J, Eriksson A, Persson L, Smits A
Low malignancy grade glioma in the
Uppsala++/Orebro region. Prognostic factors and survival among 119 patients
Lakartidningen. 2000 Sep 6;97(36):3880-4
|
|
Koh-ichi Sakata, Masato
Hareyama, Takashi Komae, Hiroki Shirato, Osamu
Watanabe, Jiroh Watarai, Kenji Takai, Shogo
Yamada, Emiko Tsuchida and Kunio Sakai
Supratentorial Astrocytomas and
Oligodendrogliomas Treated in the MRI Era
Japanese Journal of Clinical Oncology, June 2001,
31:240-245
|
|
|
Schomas DA, Laack NN, Brown PD
Low-grade
gliomas in older patients: long-Term Follow-Up From Mayo Clinic
Cancer. 2009 Jun 17. [Epub
ahead of print]
Abstract |
Links |
Issue
|
|
|
Shaw EG, Berkey B, Coons SW, Bullard D, Brachman
D, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta M.
Recurrence following neurosurgeon-determined gross-total resection of
adult supratentorial low-grade glioma: results of a prospective clinical
trial
J Neurosurg.
2008 Nov;109(5):835-841
Abstract |
Links |
Issue
|
|
|
Smith JS, Chang EF, Lamborn KR, Chang SM, Prados
MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS
Role of extent of resection in the long-term outcome of low-grade
hemispheric gliomas
J
Clin Oncol. 2008 Mar 10;26(8):1338-45
Abstract |
Links | BL 7:6
|
|
M L C van Veelen, C J J Avezaat, J M Kros, W van
Putten, Ch Vecht
Supratentorial low grade
astrocytoma: prognostic factors, dedifferentiation, and the issue of early
versus late surgery
J Neurol Neurosurg Psychiatry, May 1998;
64:581-587
|
|
S-A Yeh, MD, J-T Ho, MD,
C-C Lui, MD, Y-J Huang, MD, C-Y Hsiung, MD
and E-Y Huang, MD
Treatment outcomes and prognostic factors in patients with
supratentorial low-grade gliomas
British Journal of Radiology,
2005;
78, 230-235
|
|
|
M Wager, J Guilhot, J-L Blanc, S Ferrand, S Milin, B
Bataille, F Lapierre, S Denis, T Chantereau, C-J Larsen and L Karayan-Tapon
Prognostic value of increase in transcript levels
of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
Br J Cancer. 2006 Oct
23;95(8):1062-9.
|
|
|
Gliomatosis
Cerebri
|
|
|
|
|
Kaloshi G, Everhard S, Laigle-Donadey F, Marie
Y, Navarro S, Mokhtari K, Idbaih A, Ducray F, Thillet J, Hoang-Xuan K,
Delattre JY, Sanson M
Genetic markers predictive of chemosensitivity and outcome in gliomatosis
cerebri
Neurology. 2008 Feb 19;70(8):590-5
Abstract |
Links | BL 7:6
|
|
|
Gliosarcoma
|
|
|
|
|
Han
SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW, Berger MS, Prados MD,
Parsa AT.
Clinical characteristics and outcomes for a modern series of primary
gliosarcoma patients
Cancer. 2010 Jan 5;. [Epub ahead of print]
Abstract |
Links |
CNO 9(2)
|
|
|
Hemangioblastoma
|
|
|
|
Tago M, Terahara A, Shin M, Maruyama K, Kurita H, Nakagawa K, Ohtomo
K
Gamma knife surgery for hemangioblastomas
J
Neurosurg. 2005 Jan;102 Suppl:171-4
|
|
Wang EM, Pan L, Wang BJ, Zhang N, Zhou LF, Dong YF, Dai JZ, Cai PW, Chen
H
The long-term results of gamma knife radiosurgery for
hemangioblastomas of the brain
J
Neurosurg. 2005 Jan;102 Suppl:225-9
|
|
|
Hemangioma
|
|
|
| |
Kim MS, Pyo SY, Jeong YG, Lee SI, Jung YT, Sim
JH
Gamma knife surgery for intracranial cavernous
hemangioma
J Neurosurg.
2005 Jan;102 Suppl:102-6
|
| |
Liscak R, Vladyka V, Simonova G, Vymazal J, Novotny J
Jr
Gamma knife surgery of brain cavernous
hemangiomas
J
Neurosurg. 2005 Jan;102 Suppl:207-13)
|
|
|
PCNS
Lymphoma
|
|
|
|
Lauren E. Abrey, Leah
Ben-Porat, Katherine S. Panageas, Joachim Yahalom,
Brian Berkey, Walter Curran, Christopher Schultz,
Steven Leibel, Diana Nelson, Minesh Mehta,
Lisa M. DeAngelis
Primary Central Nervous System Lymphoma: The
Memorial Sloan-Kettering Cancer Center Prognostic Model
Journal of Clinical Oncology, Vol 24, No 36 (December 20), 2006: pp.
5711-5715; Epub November 20 2006
|
|
L.
E. Abrey, D. A. Filippa, L. M. DeAngelis
Clinical
correlation of histologic and genetic features in primary CNS lymphoma (PCNSL)
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 417
|
|
|
Kristina M. Braaten,
Rebecca A. Betensky, Laurence de Leval, Yoshifumi
Okada, Fred H. Hochberg, David N. Louis, Nancy
L. Harris and Tracy T. Batchelor
BCL-6 Expression Predicts Improved Survival in Patients with Primary
Central Nervous System Lymphoma
Clinical Cancer Research Vol. 9, 1063-1069, 1 March
2003
Abstract |
Full Text |
Reprint |
Links | BL 7:6
|
|
|
Cady FM, O'Neill BP, Law ME, Decker PA, Kurtz DM, Giannini C, Porter AB,
Kurtin PJ, Johnston PB, Dogan A, Remstein ED
Del(6)(q22)
and BCL6 rearrangements in primary CNS lymphoma are indicators of an
aggressive clinical course
J
Clin Oncol. 2008 Oct 10;26(29):4814-9. Epub 2008 Jul 21
Abstract |
Links |
Issue
|
|
|
Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D,
Johannesen TB, Mella O, Espeland A.
Increasing incidence and continued dismal outcome of primary central
nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year
national survey.
Cancer. 2007 Oct 15;110(8):1803-14
Abstract
|
Links
|
|
|
Levy O, Deangelis LM, Filippa DA, Panageas KS,
Abrey LE
Bcl-6 predicts improved prognosis in primary central nervous system
lymphoma
Cancer. 2008 Jan 1;112(1):151-6.
Published Online: 12 Nov 2007
Abstract |
Links | BL 7:6
|
|
Beela
S Mathew, Kathryn A Carson, Stuart A Grossman, Regional Cancer Centre,
Trivandrum, India; Johns Hopkins Hospital, Baltimore, MD
Initial
response to glucocorticoids: an important prognostic factor in patients
with primary CNS lymphoma (PCNSL)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 300
|
|
|
Leptomeningeal
Diseases
|
|
|
|
|
Bruna J, González L, Miró J, Velasco R, Gil M, Tortosa A; Neuro-Oncology
Unit of the Institute of Biomedical Investigation of Bellvitge
Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid
features
Cancer. 2009 Jan
15;115(2):381-9.
Abstract |
Links |
Issue
|
|
|
Medulloblastoma
|
|
|
|
|
Chen SH, Liu LY, Jaing TH, Tseng CK, Lin KL, Lui
TN.
Multivariate survival analysis of children with medulloblastoma--a
single-center experience
Pediatr
Hematol Oncol. 2008 Sep;25(7):647-54
Abstract |
Links |
Issue
|
|
|
Curran
EK, Le GM, Sainani KL, Propp JM, Fisher PG
Do
children and adults differ in survival from medulloblastoma? A study from
the SEER registry
J Neurooncol.
2009 Apr 25. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla
LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man
TK, Rao PH, Kim JY.
Medulloblastoma outcome is adversely
associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of
chromosome 8.
BMC
Cancer. 2006 Sep 12;6(1):223 [Epub
ahead of print]
Abstract |
Reprint
|
|
Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL
Combining
Gene Expression Profiles and Clinical Parameters for Risk Stratification in
Medulloblastomas
Journal
of Clinical Oncology, Vol 22, No 6 (March 15), 2004: pp. 994-998
|
|
Paul Graham Fisher, Peter C. Burger, Charles G.
Eberhart
Biologic Risk
Stratification of Medulloblastoma: The Real Time Is Now
Journal of
Clinical Oncology, Vol 22, No 6
(March 15), 2004: pp. 971-974
|
|
Amar Gajjar, Roberto Hernan, Mehmet Kocak,
Christine Fuller, Youngsoo Lee, Peter J.
McKinnon, Dana Wallace, Ching Lau, Murali
Chintagumpala, David M. Ashley, Stewart J.
Kellie, Larry Kun, Richard J. Gilbertson
Clinical,
Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease
Risk Stratification System for Medulloblastoma
Journal of Clinical
Oncology, Vol 22, No 6 (March 15), 2004: pp. 984-993
|
|
A.
J. Gajjar, R. Hernan, C. Fuller, Y. Lee, M. Kocak, C. Lau, M. Chintagumpala,
D. Ashley, S. Kellie, R. Gilbertson
Molecular markers predictive of disease
outcome in medulloblastoma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 420
|
|
C. Haberler, I. Slavc, T. Czech, E. Gelpi, H. Heinzl,
H. Budka, C. Urban, M. Scarpatetti, G. Ebetsberger-Dachs, C. Schindler, N.
Jones, A. Klein-Franke, H. Maier, B. Jauk, A. Kiefer and J.A. Hainfellner
Histopathological prognostic factors in medulloblastoma: High expression of
survivin is related to unfavourable outcome
Eur J Cancer.
2006 Sep 25; [Epub ahead of print]
Abstract
|
|
|
Hoff
KV, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz
M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD,
Kuehl J, Rutkowski S
Long-term outcome and clinical prognostic factors in children with
medulloblastoma treated in the prospective randomised multicentre trial
HIT'91
Eur
J Cancer. 2009 Feb 26. [Epub ahead of print]
Abstract
|
Links |
Issue
|
|
|
Lai R
Survival of patients with adult medulloblastoma: a population-based study
Cancer. 2008 Feb 15; [Epub
ahead of print]
Abstract |
Links | BL 7:6
|
|
|
Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK
Gain of 1q is a potential univariate negative prognostic marker for
survival in medulloblastoma
Clin
Cancer Res. 2007 Dec 1;13(23):7022-8
Abstract |
Links
|
|
|
Packer
RJ, Vezina G
Management of and prognosis with medulloblastoma: therapy at a crossroads
Arch Neurol. 2008 Nov;65(11):1419-24
Abstract |
Links |
Issue
|
|
|
Pfister
S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F,
Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD,
Radlwimmer B, Scheurlen W, Lichter P, Korshunov A.
Outcome prediction in pediatric medulloblastoma based on DNA copy-number
aberrations of chromosomes 6q and 17q and the MYC and MYCN loci
J Clin Oncol. 2009 Apr 1;27(10):1627-36. Epub 2009 Mar 2
Abstract |
Links |
Issue
|
|
|
Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C,
Thuerigen O, Sinn HP, Akhtar A, Lichter P
The histone acetyltransferase hMOF is frequently downregulated in primary
breast carcinoma and medulloblastoma and constitutes a biomarker for
clinical outcome in medulloblastoma
Int
J Cancer. 2007 Nov 30; [Epub ahead of print]
Abstract |
Links
|
|
Pomeroy
SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY,
Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore
C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis
DN, Mesirov JP, Lander ES, Golub TR
Prediction of
central nervous system embryonal tumour outcome based on gene expression
Nature. 2002 Jan 24;415(6870):436-42
|
|
|
Riffaud
L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T
Survival
and prognostic factors in a series of adults with medulloblastomas
J Neurosurg.
2009 Feb 20. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Sanders RP, Onar A, Boyett JM, Broniscer A,
Morris EB, Qaddoumi I, Armstrong GT, Boop FA, Sanford RA, Kun LE, Merchant
TE, Gajjar A.
M1 Medulloblastoma: high risk at any age
J Neurooncol.
2008 Aug 15. [Epub ahead of print]
Abstract |
Links |
BL 7:17
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
479
|
|
|
Verma S, Tavare C, Gilles F
Histologic Features and Prognosis in Pediatric Medulloblastoma
Pediatr Dev Pathol. 2008 Jan 17. [Epub ahead of print]
Abstract |
Links | BL 7:3
|
|
Paul M. Zeltzer, James M. Boyett, Jonathan
L. Finlay, A. Lel Albright, Lucy B. Rorke, Jerrold
M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens,
Philip Stanley, Hao Li, Jeffrey H. Wisoff,
J. Russell Geyer, Patsy McGuire-Cullen, James A.
Stehbens, Susan B. Shurin, Roger J. Packer
Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic
Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer
Group 921 Randomized Phase III Study
Journal of Clinical Oncology, Vol 17, Issue 3 (March),
1999: 832
|
|
|
Meningioma
|
|
|
|
|
Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL,
Curry WT Jr, Barker FG 2nd
Long-term
recurrence rates of atypical meningiomas after gross total resection with or
without postoperative adjuvant radiation
Neurosurgery. 2009
Jan;64(1):56-60
Abstract |
Links |
Issue
|
|
|
Boviatsis
EJ, Bouras TI, Kouyialis AT, Themistocleous MS, Sakas DE.
Impact of age on complications and outcome in meningioma surgery.
Surg Neurol. 2007
Jun 20; [Epub ahead of print]
PMID: 17586023 [PubMed - as supplied by publisher]
|
|
|
Durand
A, Labrousse F, Jouvet A, Bauchet L, Kalamaridès M, Menei P, Deruty R,
Moreau JJ, Fèvre-Montange M, Guyotat J
WHO
grade II and III meningiomas: a study of prognostic factors
J Neurooncol.
2009 Jun 27. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Gabeau-Lacet
D, Aghi M, Betensky RA, Barker FG, Loeffler JS, Louis DN
Bone
involvement predicts poor outcome in atypical meningioma
J Neurosurg.
2009 Mar 6. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Han JH, Kim DG, Chung HT, Park CK, Paek SH, Kim
CY, Jung HW
Gamma Knife Radiosurgery for Skull Base Meningiomas: Long-Term Radiologic
and Clinical Outcome
Int
J Radiat Oncol Biol Phys. 2008 Oct 13. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Ildan
F, Erman T, Gocer AI, Tuna M, Bagdatoglu H, Cetinalp E, Burgut R.
Predicting the probability of meningioma recurrence in
the preoperative and early postoperative period: a multivariate analysis in
the midterm follow-up.
Skull
Base. 2007 May;17(3):157-71.
Full
Text |
Reprint
|
|
|
Kim TW, Jung S, Jung TY, Kim IY, Kang SS, Kim SH.
Prognostic factors of postoperative visual outcomes in tuberculum sellae
meningioma
Br J
Neurosurg. 2008 Apr;22(2):231-4
Abstract |
Links | BL 7:7
|
|
Angel Maíllo, Alberto Orfao, José
María Sayagués, Pedro Díaz, Juan Antonio Gómez-Moreta,
Marcelino Caballero, David Santamarta, Angel
Santos-Briz, Francisco Morales, María Dolores
Tabernero
New Classification Scheme for the Prognostic Stratification of Meningioma on
the Basis of Chromosome 14 Abnormalities, Patient Age, and Tumor Histopathology
Journal of Clinical Oncology, Vol 21, Issue 17
(September 1), 2003: 3285-3295
|
|
|
Maiuri F, Donzelli R, Mariniello G, Del Basso De
Caro ML, Colella A, Peca C, Vergara P, Pettinato G
Local versus diffuse recurrences of meningiomas: factors correlated to
the extent of the recurrence
Clin Neuropathol. 2008 Jan-Feb;27(1):29-36
Abstract |
Links | BL 7:4
|
|
|
Nakasu
S, Fukami T, Nakajima M, Watanabe K, Ichikawa M, Matsuda M
Growth pattern changes of meningiomas: long-term
analysis
Neurosurgery.
2005 May;56(5):946-55
|
|
Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao
S
Matrix metalloproteinase-2 and matrix
metalloproteinase-9 expressions correlate with the recurrence of intracranial
meningiomas
J
Neurooncol. 2004 Jan;66(1-2):29-37. (Abstract+)
|
|
|
Pasquier D, Bijmolt S, Veninga T, Rezvoy N,
Villa S, Krengli M, Weber DC, Baumert BG, Canyilmaz E, Yalman D, Szutowicz
E, Tzuk-Shina T, Mirimanoff RO; Rare Cancer Network
Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119
Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer
Network
Int
J Radiat Oncol Biol Phys. 2008 Feb 22; [Epub ahead of print]
Abstract |
Links | BL 7:6
|
|
|
Sindou
M, Wydh E, Jouanneau E, Nebbal M, Lieutaud T.
Long-term follow-up of meningiomas of
the cavernous sinus after surgical treatment alone.
J Neurosurg.
2007 Nov;107(5):937-44.
Abstract
|
|
S. Soyuer, E. L. Chang, U. Selek,
M. H. Maor, F. Demonte
Operable benign meningioma patients appear to have
expected survival that is equivalent to a normal United States population
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1543
|
|
|
Strassner
C, Buhl R, Mehdorn HM
Recurrence
of intracranial meningiomas: did better methods of diagnosis and surgical
treatment change the outcome in the last 30 years?
Neurol Res.
2009 Jun 4. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Tyagi
A, Chakrabarty A, Franks A
MIB1 proliferation index in meningiomas: does it predict
recurrence? A clinicopathological study
Br
J Neurosurg. 2004 Aug;18(4):357-61
|
|
|
Metastatic
Tumors
|
|
|
|
H. Aoyama, H. Shirato, K. Nakagawa,
M. Tago
Interim report of the
JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs.
radiosurgery plus whole brain irradiation for 1-4 brain metastases
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1506
|
|
|
Barnes
EA, Chow E, Tsao MN, Bradley NM, Doyle M, Li K, Lam K, Danjoux C
Physician
Expectations of Treatment Outcomes for Patients with Brain Metastases
Referred for Whole Brain Radiotherapy
Int
J Radiat Oncol Biol Phys. 2009 Apr 20. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A,
Sawaya R, Woo SY
Outcome variation among "radioresistant" brain
metastases treated with stereotactic radiosurgery
Neurosurgery.
2005 May;56(5):936-45
|
|
Datta R, Jawahar A, Ampil FL, Shi R, Nanda A, D'Agostino H
Survival in relation to radiotherapeutic modality for brain
metastasis: whole brain irradiation vs. gamma knife radiosurgery
Am J Clin Oncol. 2004 Aug;27(4):420-4
|
|
|
Hofmann
MA, Coll SH, Kuchler I, Kiecker F, Wurm R, Sterry W, Trefzer U.
Prognostic factors and impact of treatment in melanoma brain metastases:
better prognosis for women?
Dermatology.
2007;215(1):10-6.
PMID: 17587834 [PubMed - in process]
|
|
Jawahar A, Ampil F, Wielbaecher C, Hartman GH, Zhang JH,
Nanda A
Management strategies for
patients with brain metastases: has radiosurgery made a difference?
South Med J. 2004 Mar;97(3):254-8
|
|
Douglas Kondziolka, M.D., M.Sc., Juan J. Martin, M.D., John C. Flickinger,
M.D., David M. Friedland, M.D., Adam M. Brufsky, M.D., Ph.D., Joseph Baar,
M.D., Sanjiv Agarwala, M.D., John M. Kirkwood, M.D., L. Dade Lunsford,
M.D.
Long-term
survivors after gamma knife radiosurgery for brain metastases
Cancer, Volume 104, Issue 12 , Pages
2784 - 2791 (15 December 2005). Published Online: 15 Nov 2005
Abstract
| BrainLife
|
News
|
|
|
Molenaar
R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C
Relationship
between volume, dose and local control in stereotactic radiosurgery of brain
metastasis
Br J
Neurosurg. 2009 Apr;23(2):170-8
Abstract |
Links |
Issue
|
|
|
Patil CG, Lad SP, Santarelli J, Boakye M
National inpatient complications and outcomes after surgery for spinal
metastasis from 1993-2002
Cancer. 2007 Aug 1;110(3):625-30.
Epub 2007 Jun 18
Abstract |
Links
|
|
|
Park BB, Uhm JE, Cho EY, Choi YL, Ji SH, Nam DH,
Il Lee J, Park W, Huh SJ, Park YH, Ahn JS, Im YH
Prognostic factor analysis in patients with brain metastases from breast
cancer: how can we improve the treatment outcomes?
Cancer Chemother Pharmacol. 2008 Jun 14; [Epub ahead of print]
Abstract |
Links |
BL 7:13
|
|
P
Rodrigus, M P Mehta, C Terhaard, A Rao, J Suh, W Roa, L Souhami, A
Bezjak, M Leibenhaut, R Komaki, C Schultz, R Timmerman, T Illidge, C
Meyers, W J Curran, SC Phan, J Smith, MF Renschler
Impaired
neurocognitive function (NCF) in brain metastasis (BM) patients (pts) is
strongly correlated with MRI tumor volume and tumor histology: baseline
results from the phase III trial of motexafin gadolinium (MGd)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
292
|
|
Rahul D. Tendulkar M.D., Stephanie W. Liu B.A., Gene
H. Barnett M.D., Michael A. Vogelbaum M.D., Ph.D., Steven A. Toms M.D., M.P.H.,
Tao Jin M.S. and John H. Suh M.D.
RPA classification has prognostic significance for surgically resected single
brain metastasis
Int
J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):810-7. Available online 28
September 2006.
Abstract
|
|
|
Sperduto
PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown
PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V,
Knisely J, Sperduto CM, Mehta M
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes
for Patients with Newly Diagnosed Brain Metastases: A Multi-Institutional
Analysis of 4,259 Patients
Int
J Radiat Oncol Biol Phys. 2009 Nov 24. [Epub ahead of print]
Abstract |
Links |
CNO 9(1)
|
|
|
Sperduto CM, Watanabe Y, Mullan J, Hood T, Dyste G, Watts C, Bender GP,
Sperduto P
A
validation study of a new prognostic index for patients with brain
metastases: the Graded Prognostic Assessment
J Neurosurg.
2008 Dec;109 Suppl:87-9
Abstract |
Links |
Issue
|
|
|
Waki
F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, Tateishi U, Tsuta
K, Shimada Y, Fujiwara Y, Tamura T
Prognostic
factors and clinical outcomes in patients with leptomeningeal metastasis
from solid tumors
J Neurooncol.
2009 Jun;93(2):205-12. Epub 2008 Nov 29
Abstract |
Full Text |
Reprint |
Links |
CNO 8(11)
|
|
Metastasis
to the Brain stem
|
|
|
|
Lorenzoni JG, Devriendt D, Massager N, Desmedt F, Simon S, Van Houtte P, Brotchi J,
Levivier M
Brain
stem metastases treated with radiosurgery: prognostic factors of survival
and life expectancy estimation
Surg Neurol.
2009 Feb;71(2):188-95; discussion 195, 195-6. Epub 2008 Apr 24
Abstract |
Links |
Issue
|
|
Metastasis
to the Cerebellum
|
|
|
|
Pompili A, Carapella CM, Cattani F, Fabi A,
Giannarelli D, Giovannetti M, Mirri A, Occhipinti E, Telera S, Vidiri A,
Pace A.
Metastases to the cerebellum. Results and prognostic factors in a
consecutive series of 44 operated patients
J Neurooncol.
2008 Jul;88(3):331-7.
Epub 2008 Apr 8
Abstract |
Links | BL 7:18
|
|
Metastasis
of Breast Cancer
|
|
|
|
Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio
K, Hortobagyi GN, Rivera E
Clinicopathologic characteristics and prognostic factors in 420
metastatic breast cancer patients with central nervous system metastasis
Cancer. 2007 Dec 15;110(12):2640-7;
Published Online: 25 Oct 2007
Abstract |
Links | BL 7:4
|
|
|
Eichler
AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW
Survival in patients with brain metastases from breast cancer: the
importance of HER-2 status
Cancer. 2008 Mar 24; [Epub
ahead of print]
Abstract |
Links | BL 7:8
|
|
Muacevic A, Kreth FW, Tonn JC, Wowra B
Stereotactic radiosurgery
for multiple brain metastases from breast carcinoma
Cancer. 2004 Apr 15;100(8):1705-11
|
|
|
Nieder
C, Marienhagen K, Astner ST, Molls M
Prognostic
scores in brain metastases from breast cancer
BMC Cancer. 2009 Apr
7;9(1):105. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
Mets
of Carcinoid Tumors |
|
|
Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito
F
Single brain metastases of carcinoid tumors
J Neurooncol. 2004 Feb;66(3):327-32
|
|
Mets of Colorectal Cancer |
|
|
C. Garufi, B. Vanni, C.
Francesca, C. Campanella, A. M. Aschelter, E. Bria, C. Nisticò, F. Cuppone,
I. Sperduti, E. Terzoli
Evidence for an
aggressive biological behaviour of brain metastases in advanced colorectal
cancer patients
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1579
|
|
Mets
of Gynecological Canc. |
|
|
Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF,
Gershenson DM, Sawaya R
Brain metastases in
patients with ovarian carcinoma: prognostic factors and outcome
J
Neurooncol. 2004 Feb;66(3):313-25. (Abstract+)
|
|
Kim
TJ, Song S, Kim CK, Kim WY, Choi CH, Lee JH, Lee JW, Bae DS, Kim BG.
Prognostic factors associated with brain metastases from epithelial ovarian
carcinoma.
Int
J Gynecol Cancer. 2007 Apr 18; [Epub ahead of print]
PMID: 17442021 [PubMed - as supplied by publisher]
|
|
|
Ogawa K, Yoshii Y, Aoki Y, Nagai Y, Tsuchida Y,
Toita T, Kakinohana Y, Tamaki W, Iraha S, Adachi G, Hirakawa M, Kamiyama K,
Inamine M, Hyodo A, Murayama S
Treatment and prognosis of brain metastases from gynecological cancers
Neurol Med Chir (Tokyo). 2008 Feb;48(2):57-63
Abstract |
Reprint |
Links | BL 7:5
|
|
Metastasis of
Lung Cancer |
|
|
Chee
R, Bydder S, Cameron F.
Prolonged survival after resection and radiotherapy for
solitary brain metastases from non-small-cell lung cancer.
Australas Radiol.
2007 Apr;51(2):186-9.
PMID: 17419869 [PubMed - in process]
|
|
Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ,
Livingston RB, Gandara DR
Time From Treatment to Subsequent Diagnosis of Brain
Metastases in Stage III Non-Small-Cell Lung Cancer: A Retrospective Review
by the Southwest Oncology Group
J
Clin Oncol. 2005 May 1;23(13):2955-61
|
|
Jawahar A, Matthew RE, Minagar A, Shukla D, Zhang JH,
Willis BK, Ampil F, Nanda A
Gamma knife surgery
in the management of brain metastases from lung carcinoma: a retrospective
analysis of survival, local tumor control, and freedom from new brain metastasis
J Neurosurg. 2004 May;100(5):842-7
|
|
|
Sheehan J, Kondziolka D, Flickinger J, Lunsford
LD
Radiosurgery for patients with recurrent small cell lung
carcinoma metastatic to the brain: outcomes and prognostic factors
J
Neurosurg. 2005 Jan;102 Suppl:247-54
|
|
|
Videtic
GM, Reddy CA, Chao ST, Rice TW, Adelstein DJ, Barnett GH, Mekhail TM,
Vogelbaum MA, Suh JH.
Gender, Race, and Survival: A Study in Non-Small-Cell Lung Cancer Brain
Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive
Partitioning Analysis Classification
Int J Radiat Oncol Biol Phys. 2009 Mar 25;. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
G. M. Videtic, D. J. Adelstein,
T. Mekhail, T. W. Rice, G. H. J. Stevens, S.-Y. Lee, J. H. Suh
Validation of the
RTOG recursive partitioning analysis (RPA) classification for small cell
lung cancer-only brain metastases: A single institution experience
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1557
|
|
Melanoma
brain metastases
|
|
|
Harrison
BE, Johnson JL, Clough RW, Halperin EC
Selection
of patients with melanoma brain metastases for aggressive treatment
Am J Clin Oncol. 2003 Aug;26(4):354-7
|
|
|
Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S,
Markert JM
Initial treatment of melanoma brain metastases using gamma
knife radiosurgery: an evaluation of efficacy and toxicity
Cancer. 2004 Aug 15;101(4):825-33
|
|
Mets
of Prostate Carcinoma |
|
|
Ars C, Duck L, Baurain JF, Moulin P, Duprez T,
Machiels JP
Unusual metastatic features
in a patient with concomitant malignant orbital melanoma and prostate
carcinoma
J Neurooncol. 2004 Feb;66(3):361-3
|
|
Mets of Renal Cell Carcinoma |
|
|
Vecil GG, Lang FF
Surgical resection of
metastatic intraventricular tumors
Neurosurg Clin N Am. 2003 Oct;14(4):593-606
|
|
Mets
of undiagn.
primary t.
|
|
|
|
D'Ambrosio
AL, Agazzi S.
Prognosis in patients presenting with brain metastasis from an undiagnosed
primary tumor.
Neurosurg Focus.
2007 Mar 15;22(3):E7.
 PMID:
17608360 [PubMed - in process]
|
|
|
Mixed Gliomas
|
|
|
|
Bissola L, Eoli M, Merciai B, Silvani A,
Salsano E, Broggi G, Boiardi A and Finocchiaro G
Allelic losses on chromosomes 1p, 19q, 17p and 10q as
predictors of survival in oligoastrocytomas
Proc. Int. Symp. "New Treatments for Brain Tumors: Gene Therapy and Neural
Stem Cells", Parma, Italy, October 17-20, 2001, Abstract No. P-1
|
|
Jan C
Buckner, Bernd W Scheithauer, Robert P Dinapoli, Henry J Votava, Caterina
Giannini, Nancy Iturria, Judith O'Fallon
Comparison
of mixed anaplastic oligoastrocytoma and high-grade astrocytoma in North Central
Cancer Treatment Group (NCCTG) clinical trials of high-grade glioma
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No.
305
|
|
Jeremic B, Milicic B, Grujicic D, Samardzic M,
Antunovic V, Dagovic A, Aleksandrovic J
Combined treatment
modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year
update of a phase II study
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):509-14
|
|
C. Ryan Miller, Christopher
P. Dunham, Bernd W. Scheithauer, Arie Perry
Significance of Necrosis in Grading of
Oligodendroglial Neoplasms: A Clinicopathologic and Genetic Study of Newly
Diagnosed High-Grade Gliomas
Journal of Clinical Oncology, Vol 24, No 34 (December 1), 2006: pp.
5419-5426.
DOI: 10.1200/JCO.2006.08.1497
|
|
|
Neoplastic
Meningitis
|
|
|
|
|
Chamberlain MC, Johnston SK, Glantz MJ
Neoplastic
meningitis-related prognostic significance of the Karnofsky performance
status
Arch Neurol.
2009 Jan;66(1):74-8
Abstract |
Links |
Issue
|
|
|
Non-Nervous System
Tumors
|
|
|
|
Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani
S
Long-term results of gamma knife surgery for growth
hormone-producing pituitary adenoma: is the disease difficult to cure?
J
Neurosurg. 2005 Jan;102 Suppl:119-23
|
|
Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, Ferrari da
Passano C, Giovanelli M
Radiosurgery and the prevention of regrowth of
incompletely removed nonfunctioning pituitary adenomas
J
Neurosurg. 2005 Jan;102 Suppl:71-4
|
|
Rubini M, D'Ambrosio C, Carturan S,
Yumet G, Catalano E, Shan S, Huang Z, Criscuolo M, Pifferi M, Baserga R
Characterization
of an antibody that can detect an activated IGF-I receptor in human
cancers
Exp Cell Res. 1999 Aug 25;251(1):22-32
|
|
|
Oligodendroglial
Tumors
|
|
|
|
B. S. Abdulkarim, A. Hasbini, J.
Cougnard, L. Djafari, C. Lacroix, F. Parker, C. Haie, C. Cioloca, E. Deutsch, E.
Raymond
Baseline pathological and radiological assessment
of tumor angiogenesis predicts survival in patients with oligodendrogliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1545
|
|
L. S. Ashby, J. K. Pueschel, A. C.
Scheck, S. W. Coons, W. R. Shapiro
Prognostic factors for
patients with newly diagnosed low-grade oligodendroglial tumors: molecular
genetics, histopathology, and neuroimag
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1501
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1501
|
|
|
Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A,
Bogdahn U, Beier CP
CD133
expression and cancer stem cells predict prognosis in high-grade
oligodendroglial tumors
Brain
Pathol. 2008 Jul;18(3):370-7. Epub 2008 Mar 27
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Buckner JC, O'Fallon JR, Dinapoli RP, Schomberg
PJ, Farr G, Schaefer P, Giannini C, Scheithauer BW, Ballman KV.
Prognosis in patients with anaplastic oligoastrocytoma is associated with
histologic grade.
J Neurooncol. 2007
Sep;84(3):279-86. Epub 2007 Apr 13.
Abstract
|
|
JG Cairncross, K Ueki, MC Zlatescu, DK
Lisle, DM Finkelstein, RR Hammond, JS Silver, PC Stark, DR Macdonald, Y Ino,
DA Ramsay and DN Louis
Specific genetic predictors
of chemotherapeutic response and survival in patients with anaplastic
oligodendrogliomas
Journal Of The National Cancer Institute, Vol 90, 1473-1479; 7 October
1998
|
|
M. Frenay, A. Ramaioli, D.
Fontaine, V. Bourg, F. Vandenbos, C. Lebrun
Prognostic factors of oligodendrogliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1560
|
|
M.
Frenay, C. Lebrun, A. Ramaioli, D. Fontaine, V. Bourg, J.-F. Michiels
5-years
follow-up in 90 patients with oligodendroglial tumors
39th ASCO Annual
Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
435
|
|
Hamlat A, Saikali S, Chaperon J,
Le Calve M, Gedouin D, Ben-Hassel M, Guegan Y
Oligodendroglioma: clinical study and
survival analysis correlated with chromosomal anomalies
Neurosurg Focus.
2005 Nov 15;19(5):E15
|
|
Hoang-Xuan
K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P,
Capelle L, Delattre JY, Poirier J, Broet P, Sanson M
Molecular
heterogeneity of oligodendrogliomas suggests alternative
pathways in tumor progression
Neurology.
2001 Oct 9;57(7):1278-81
|
|
|
Idbaih A, Crinière E, Marie Y, Rousseau A,
Mokhtari K, Kujas M, El Houfi Y, Carpentier C, Paris S, Boisselier B,
Laigle-Donadey F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY
Gene amplification is a poor prognostic factor in anaplastic
oligodendrogliomas
Neuro Oncol. 2008
Jun 10. [Epub ahead of print]
Abstract |
Links |
BL 7:14
|
|
|
Kouwenhoven
MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van
Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L,
Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ
Molecular
analysis of anaplastic oligodendroglial tumors in a prospective randomized
study: A report from EORTC study 26951
Neuro Oncol. 2009
Feb 17. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
C. Lebrun, MD, D.
Fontaine, MD, A. Ramaioli, PhD, F. Vandenbos, MD,
S. Chanalet, MD, M. Lonjon, MD PhD, J. F.
Michiels, MD PhD, V. Bourg, MD, P. Paquis, MD PhD,
M. Chatel, MD, M. Frenay, MD and The Nice Brain
Tumor Study Group
Long-term outcome of
oligodendrogliomas
Neurology, 62:1783-1787; 25 May 2004
|
|
Jon D. Olson, MD, Elyn
Riedel, MA and Lisa M. DeAngelis, MD
Long-term outcome of low-grade
oligodendroglioma and mixed glioma
Neurology 54:1442-1448; 11 April 2000. (Abstract+)
|
|
Walker C, du Plessis DG, Joyce KA,
Fildes D, Gee A, Haylock B, Husband D, Smith T, Broome J, Warnke PC
Molecular pathology and clinical
characteristics of oligodendroglial neoplasms
Ann Neurol. 2005
Jun;57(6):855-65
|
|
|
Weller
M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex
D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A; German
Glioma Network
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic
biomarker?
Clin
Cancer Res. 2007 Dec 1;13(23):6933-7
Abstract |
Links | BL 7:11
|
|
|
Pediatric Brain Tumors
|
|
|
|
|
Armstrong
GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS,
King AA, Stovall M, Krull KR, Robison LL, Packer RJ
Long-term
outcomes among adult survivors of childhood central nervous system
malignancies in the Childhood Cancer Survivor Study
J
Natl Cancer Inst. 2009 Jul 1;101(13):946-58. Epub 2009 Jun 17
Abstract |
Links |
Issue
|
|
|
Rafael Peris-Bonet,
Carmen Martínez-García, Brigitte Lacour, Svetlana Petrovich,
Begoña Giner-Ripoll, Aurora Navajas and Eva Steliarova-Foucher
Childhood
central nervous system tumours – incidence and survival in Europe
(1978–1997): Report from Automated Childhood Cancer Information System
project
Eur J Cancer.
2006 Sep;42(13):2064-80. Epub 2006 Aug 17. doi:10.1016/j.ejca.2006.05.009
|
|
|
Pilocytic
Astrocytoma
|
|
|
|
Daniel C. Bowers, Lynn Gargan, Payal
Kapur, Joan S. Reisch, Arlynn F. Mulne, Kenneth
N. Shapiro, Roy D. Elterman, Naomi J. Winick, Linda
R. Margraf
Study of the MIB-1 Labeling Index as a Predictor of Tumor Progression in
Pilocytic Astrocytomas in Children and Adolescents
Journal of Clinical Oncology, Vol 21, Issue 15
(August), 2003: 2968-2973. (Abstract+)
|
|
L. Girard, J. D. Minna, T.
Chen, G. Tomlinson, D. Bowers
Gene expression
profiling of progressive and stable childhood pilocytic astrocytomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8546
|
|
|
Pineal
Tumors |
|
|
|
Amendola BE, Wolf A, Coy SR, Amendola MA, Eber D
Pineal tumors: analysis of treatment results in 20
patients
J
Neurosurg. 2005 Jan;102 Suppl:175-9
|
|
|
Pleomorphic
Xanthoastrocytoma |
|
|
|
|
Ng WH, Lim T, Yeo TT
Pleomorphic xanthoastrocytoma in elderly patients may portend a poor
prognosis
J Clin Neurosci. 2008 Feb 6; [Epub ahead of print]
Abstract |
Links | BL 7:4
|
|
|
Pseudo-progression
|
|
|
|
|
Taal
W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Sillevis Smitt
PA, van Es CA, van den Bent MJ.
Incidence of early pseudo-progression in a cohort of malignant glioma
patients treated with chemoirradiation with temozolomide
Cancer. 2008 May 16. [Epub
ahead of print]
Abstract |
Links | BL 7:11
|
|
|
Spinal
Cord Tumors
|
|
|
|
Constantini
S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ
Radical
excision of intramedullary spinal cord tumors: surgical morbidity and
long-term follow-up evaluation in 164 children and young adults
J Neurosurg. 2000 Oct;93(2 Suppl):183-93
|
|
D.
A. Loblaw, K. Smith, G. Lockwood, N. Laperriere
The Princess Margaret
Hospital Experience of malignant spinal cord compression
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 477
|
|
|
McGirt MJ, Chaichana KL, Atiba A, Attenello F, Woodworth GF, Jallo GI
Neurological
outcome after resection of intramedullary spinal cord tumors in children
Childs
Nerv Syst. 2008 Jan;24(1):93-7. Epub 2007 Jul 31
Abstract |
Full Text |
Reprint |
Links |
Issue
|
|
|
Milano
MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA
Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results
database study
J Neurooncol. 2009 Nov 7;. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Links |
CNO 8(12)
|
|
A.
E. Sloan, S. Lo, K. Levin, A. Frazier, L. Gaspar, Karmanos Cancer Institute,
Wayne State
Outcome of
radiation therapy for intramedullary spinal cord glioma-Wayne State University
experience
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003.
Abstract No. 449
|
|
|
SPNET
|
|
|
|
|
Krampulz T, Hans VH, Oppel F, Dietrich U, Puchner
MJ.
Long-term relapse-free survival with
supratentorial primitive neuroectodermal tumor in an adult: a case report.
J
Neurooncol. 2006 May;77(3):291-4.
Epub 2006 Mar 10.
Abstract
|
|
PNET
|
|
|
|
Kampman WA, Kros JM, De Jong TH,
Lequin MH
Primitive neuroectodermal tumours (PNETs) located in the spinal
canal; the relevance of classification as central or peripheral
PNET : case report of a primary spinal PNET occurrence with a
critical literature review.
J Neurooncol. 2006 Mar;77(1):65-72. Epub 2005 Nov 15.
Abstract
|
|
|
Stem
Cells
|
|
|
|
|
Pallini R, Ricci-Vitiani L, Banna GL, Signore M,
Lombardi D, Todaro M, Stassi G, Martini M, Maira G, Larocca LM, De Maria R
Cancer
stem cell analysis and clinical outcome in patients with glioblastoma
multiforme
Clin
Cancer Res. 2008 Dec 15;14(24):8205-12
Abstract |
Links |
Issue
|
|
|
|
bottom
|
